Lipases and their interaction partners in Gallus gallus by Besenböck, Carolin
DIPLOMARBEIT
Titel der Diplomarbeit
Lipases and their Interaction 
Partners in Gallus gallus
angestrebter akademischer Grad
Magistra der Naturwissenschaften (Mag. rer.nat.) 
Verfasserin:  Carolin Besenböck
Matrikel-Nummer:  0401610
Studienrichtung /
Studienzweig (lt. 
Studienblatt):
 Molekulare Biologie
Betreuerin / Betreuer:  O. Univ. Prof. DI. Dr. Wolfgang J. Schneider
Wien, im  Juli 2010

Table of contents
..........................................................................................................1. Introduction 9
.................................................................................................1.1 The chicken as a model organism 9
..................................................................................1.2 The Lipid droplet as a complex organelle  11
................................................................................................1.3 Lipid trafficking: a brief overview 14
.....................................................................1.4 Energy Homoestasis: Lipogenesis and Lipolysis 17
.........................................................................................................1.4.2 Patatin-like Phospholipases 21
..........................................................1.4.2.1  ATGL (Adipocyte Triglyceride Lipase; PNPLA2) 25
.............................................................................................1.4.3 Arylacetamide Deacteylase (AADA) 28
........................................................................................................................1.5 Aims of the Thesis 30
......................................................................................2. Materials and Methods 31
..............................................................................................................2.1 Chemicals and Enzymes 31
.........................................................................................2.2 Bacterial Strains and Vector Systems 31
.................................................................................................................2.3 Oligonucleotide Primer 36
...............................................................................................................2.4 Antisera and Antibodies 38
..........................................................................................................................................2.5 Animals 38
...........................................................................................2.6 Molecular Biological Methods: DNA  38
...........................................................................................................................2.6.1 cDNA Synthesis 38
.............................................................................................2.6.2 Polymerase Chain Reaction (PCR) 39
.............................................................................................................2.6.3 DNA Gel Electrophoresis 39
......................................................................................................................2.6.4 DNA Gel Extraction 39
.......................................................................................................................2.6.5 Vector Preparation 40
................................................................................................................................2.6.6 DNA Ligation 40
.............................................................................................2.6.7 Transformation of competent E.coli 41
.................................................................................................2.6.8 Mini preparation of Plasmid DNA 41
.................................................................................................2.6.9 Midi preparation of Plasmid DNA 42
...................................................................................2.6.10 Quantitative Real Time PCR (RT-qPCR) 42
...........................................................................................2.7 Molecular Biological Methods: RNA  43
...................................................................................................................2.7.1 Isolation of total RNA 43
.....................................................................................................2.8 Biochemical Methods: Protein 43
.......................................................................2.8.1 Preparation of Triton X-100 Total Protein Extracts 43
.............................................................2.8.2 Preparation of Triton X-100 Membrane Protein Extracts 44
......................................................................2.8.3 Determination of Protein Concentration (Bradford) 44
...................................................................................2.8.4 SDS-Polyacrylamide Gel Electrophoresis 45
..................................................................................................................2.8.6 Western Blot Analysis 46
.....................................................................................................................2.8.8 Antibody Generation 48
...........................................................2.8.9 Chromogenic Esterase Assay using pNitrophenyl-Esters 48
................................2.8.10 Fluorogenic Lipase assay using 4-methyl umbelliferyl heptanoate (MUH) 49
.................................................................................................................2.9 Immunohistochemistry 50
............................................................2.9.1 Isolation and Cultivation of chicken primary hepatocytes 50
..........................................2.9.2 Fixation and Fluorescence Staining of chicken primary hepatocytes 50
................................................................................................................3. Results 51
.............................................................3.2 Monitoring of PNPLA3 expression in different tissues 54
.........................................................................3.3. Influence of fasting and refeeding on PNPLA3 55
.............................................................................3.4 Influence of hormonal treatment on PNPLA3 58
....................................3.5 Influence of treatment with TO901317 on PNPLA3 mRNA expression 60
.....................................................3.5 Immunohistochemistry of PNPLA3 in primary hepatocytes 61
...................................................................................3.6 Effect of fasting and refeeding on AADA  62
.......................................................3.6 Analysis of tissue specific expression of AADA isoforms 64
.......................................................................3.8 Cloning, expression and purification of ggStAR 65
........................................3.9 Search for evidence that AADA substitutes for HSL in the chicken 66
................................................................................................3.8.1 AADA activity against pNP-esters 66
..........................................................................................................3.8.2 AADA activity against MUH 69
..........................................................................................................4. Discussion 71
..........................................................................................................5. References 75
.....................................................................................................6. Abbreviations 81
...........................................................................................................Danksagung 85
....................................................................................................Curriculum Vitae  87
       
Abstract
Although fat generally has a bad reputation, it is essential for many functions of the human 
body. Cholesterol, for example, is necessary for assembly of cell membranes; triglycerides 
form large energy stores for times of nutritional  scarcity and are also precursors in many 
other metabolic  pathways that give rise to substances needed by the body. Whether lipids 
are stored or re-mobilised to gain energy is a tightly regulated process. This regulation is 
important, as de-regulated lipid metabolism may result in diseases such as arteriosclerosis, 
heart attacks, diabetes, and/or the associated metabolic syndrome.
Lipases are important enzymes involved in the metabolism of lipids. A relatively newly 
defined family of lipases are the patatin-like phospholipases. These proteins all have a 
common domain derived from patatin, a protein first identified in potato tubers. In potatoes, 
patatin serves not only as a hydrolase, but also as a storage protein. It has been shown that 
some members of the patatin-like phospholipase family fulfil  their function rather as lipase, 
whereas others don’t show lipase activity at all. One family member with unclear function is 
PNPLA3. PNPLA3 shares remarkable homology with ATGL, which was shown to be a very 
important lipase in adipose tissue, However, PNPLA3 does not exhibit lipase activity in vivo, 
and  upon changes in nutrition, PNPLA3 is regulated exactly opposite to ATGL. One part of 
this work was to find out more about the function of PNPLA3 in our model  organism, the 
chicken (Gallus gallus). At the mRNA level, it was already known which chicken tissues 
express PNPLA3. Here, to monitor PNPLA3 at the protein level, an α-PNPLA3 antibody was 
raised. Then, the expression of PNPLA3 under different conditions (e.g. fasting, hormonal 
treatment) was quantitated at the mRNA level  using qPCR, and at the protein level  using 
Western Blotting.  Employing these techniques, it was shown that PNPLA3, as suggested 
before, acts in vivo as a protein that aids lipid storage rather than as a lipase. Indications for 
this are that PNPLA3 expression decreases upon fasting and increases upon refeeding, 
likely to store lipids and replenish energy stores. Also the fact that PNPLA3 is higher in 
adipose and liver of a mutant hyperlipidemic  chicken strain than in normal laying hen tissues 
indicates a role in lipid storage. Unfortunately, the entire cDNA sequence of PNPLA3 in the 
chicken is not known. Therefore, it is not yet possible to produce PNPLA3 recombinantly and 
in order to further test its lipase activity.
The breakdown of triglycerides is achieved in several  steps that depend on various 
enzymes. The first key enzyme is ATGL, which breaks down triglycerides into diglycerides 
and fatty acids. The diglycerides have to be cleaved into monoglycerides, a step that in 
humans is catalyzed by HSL (hormone sensitive lipase). In chickens, the enzyme that breaks 
down diglycerides has not been identified so far; however, the breakdown occurs. 
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It was shown that AADA (arylacetamide deacetylase) in rodents and humans shares 
significant homologies with HSL and also exhibits esterase activity. Therefore we 
hypothesized that AADA may fulfil the function of HSL in the chicken. Changes in AADA 
expression upon different conditions (fasting, refeeding, etc.) were monitored at mRNA and 
protein levels. 
I tested whether there is an AADA-like protein that is predominantly present in fat tissue 
(HSL is abundant in fat tissue, AADA rather in the liver) and finally, performed assays to test 
(i) for esterase and lipase activity of AADA and (ii) if known interaction partners of 
mammalian HSL would also interact with chicken AADA. 
The obtained results were contradicting: no interaction between AADA and FABP4, a known 
binding partner of HSL was detected, but apparently StAR, another HSL interaction partner, 
was able to modulate AADA activity against certain substrates in esterase and lipase assays. 
Interestingly, StAR itself showed detectable endogenous activity against 4-methylumbelliferyl 
hepanotate, a substrate used in lipase assays; however, StAR does not share common 
lipase motifs nor any other common lipase feature. Further investigations are required to 
elucidate if StAR has other functions apart from its known role as cholesterol transporter, and 
to definitely answer the question whether AADA indeed can substitute for HSL in the chicken.
         ABSTRACT__________________________________________________________________
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Zusammenfassung
Fette sind essentiell für viele Funktionen unseres Körpers. Cholesterin ist ein wichtiger 
Bestandteil jeder Zellmembran, Triglyzeride stellen große Energiespeicher dar und sind oft 
Ausgangsmaterial  für den Aufbau anderer vom Körper benötigter Stoffe. Ob Fette eher zur 
Speicherung eingelagert oder abgebaut werden, um Energie zu mobilisieren, wird vom 
Körper mithilfe von Enzymen reguliert. Diese Regulierung ist wichtig, da ein falsch regulierter 
Fettstoffwechsel die Ursache bzw. ein Faktor für verschiedenste Erkrankungen, wie 
Arteriosklerose, Herzinfarkt, Diabetes, oder das häufig damit assoziierte Metabolische 
Syndrom sein kann.
Lipasen sind wichtige Enzyme, die am Abbau von Fetten beteiligt sind. Eine jüngst definierte 
Familie von Lipasen ist jene der Patatin-like Phospholipases (PNPLAs). Diese Lipase-
Familie lässt sich strukturell auf ein Protein zurückführen, das Patatin aus der Kartoffelknolle. 
Patatin hat in der Kartoffel  einerseits Hydrolaseaktivität, dient aber andererseits auch als 
Speicherprotein. Für die Proteine der Patatin-like Phospholipases hat sich gezeigt, dass 
nicht alle Familienmitglieder wirklich eine Aufgabe als Lipase erfüllen. Ein Familienmitglied, 
dessen Rolle derzeit eher unklar ist, ist PNPLA3. Einerseits zeigt PNPLA3 große strukturelle 
Gemeinsamkeit mit ATGL, einem Protein, das eindeutig eine Lipase ist, hat aber 
andererseits in vivo selbst keine detektierbare Lipase-Aktivität, und wird auch genau 
umgekehrt zu ATGL reguliert. Teil dieser Arbeit war es, die Funktion des PNPLA3 in unserem 
Modell-Organismus, dem Huhn (Gallus gallus), weiter zu klären. Da bisher nur auf dem 
mRNA Niveau bekannt war, in welchen Geweben des Huhnes PNPLA3 exprimiert wird, 
wurde PNPLA3 nun auch auf dem Protein-Niveau betrachtet. Dafür wurde ein anti-PNPLA3 
Antikörper hergestellt. Die Expression von PNPLA3 wurde unter verschiedenen 
Bedingungen (Fasten, Hormonelle Behandlung, etc.) nicht nur auf dem mRNA sondern auch 
auf dem Protein-Niveau erforscht. Daraus ergab sich, dass PNPLA3, wie schon häufiger 
vermutet, im Körper offenbar eher die Funktion eines Aufbauproteins als die einer Lipase 
übernimmt. Hinweise dafür sind etwa, dass die PNPLA3 Expression beim Fasten eher 
abnimmt und stark ansteigt wenn das Fasten abgebrochen wird. Außerdem ist PNPLA3 in 
Fett und Leber von mutanten, hyperlipidämischen RO Hühnern, welche mehr Lipide 
einlagern, stärker exprimiert als in normalen Hühnern.  Da im Huhn nicht die gesamte cDNA-
Sequenz des PNPLA3 Gens bekannt ist, ist es leider nicht möglich, PNPLA3 rekombinant 
herzustellen, um dann z.B. Lipase-Assays durchzuführen, und die Funktion von PNPLA3 als 
Lipase so weiter zu widerlegen – dies ist für künftige Arbeiten geplant.
Der Abbau von Triglyzeriden durch die sogenannte Lipolyse erfolgt in mehreren Schritten 
und ist von mehreren Enzymen abhängig. Im Menschen erfolgt der Abbau von Triglyzeriden 
zu Diglyzeriden und einer Fettsäure mithilfe von ATGL (adipocyte triglyceride lipase), das 
Diglyzerid wird dann von HSL (hormone sensitive lipase) weiter abgebaut. 
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Im Huhn ist kein Enzym bekannt, das in der Lage ist Diglyzeride abzubauen, dennoch findet 
dieser Schritt statt. Da gezeigt wurde, dass AADA (Arylacetamid Deacetylase) nennenswerte 
Homologie mit HSL sowie Esterase-Aktivität besitzt, wollten wir herausfinden, ob AADA im 
Huhn möglicherweise die Aufgabe von HSL übernimmt. 
Dafür wurde auf mRNA- und Proteinebene beobachtet, wie sich die AADA Expression unter 
verschiedenen Ernährungsbedingungen ändert, und ob es eine AADA Isoform gibt, die 
vorwiegend im Fett vorkommt (HSL ist in Fettgeweben reichlich vorhanden, AADA kommt 
eher in der Leber vor). Es wurden Versuche gemacht, um zu bestimmen ob AADA Esterase- 
bzw. Lipaseaktivität besitzt, und ob Interaktionspartner von HSL (FABP4, StAR) auch mit 
AADA interagieren können. Hier gab es widersprüchliche Ergebnisse: einerseits konnte 
Interaktion zwischen AADA und FABP4festgestellt werden. Andererseits konnte StAR die 
Aktivität von AADA - zumindest gegenüber gewissen Substraten, die in Lipase bzw. Esterase 
assays verwendet werden - modulieren. Interessanterweise zeigte StAR auch selbst Aktivität 
gegenüber einem dieser Substrate, 4-Methylumbelliferrylheptanoat (MUH), obwohl nicht 
bekannt war, dass StAR Lipaseaktivität besitzt und auch strukturell keine Gemeinsamkeiten 
mit Lipasen zeigt. Weitere Forschungsarbeit wird nötig sein, erstens um zu klären, ob StAR 
weitere bisher unbekannte Funktionen im Fettstoffwechsel besitzt, und zweitens, ob AADA 
wirklich HSL im Huhn ersetzen kann, da diese Frage noch nicht eindeutig beantwortet 
werden kann.
   ZUSAMMENFASSUNG______________________________________________________________
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1. Introduction
1.1 The chicken as a model organism
The domesticated chicken (Gallus gallus domesticus) is the premier non-mammalian model 
organism in disciplines such as developmental biology or medical research. It has been already  used 
as a model in the pre-genomic era and served William Harvey, when he performed  experiments 
which revealed the morphology and function of the blood circulation system (Harvey, 1628).  
Now that the chicken genome is almost entirely  deciphered, there are even more implications for 
the chicken as a model than before. The chicken genome is composed of approximately 1.2 billion 
base pairs and approximately 16.000-20.000 genes organized in 39 chromosomes, of which 9 are 
so-called macro- and 30 are so-called micro-chromosomes. There are indications that the micro-
chromosomes are by far richer in genes than macro-chromosomes (McQueen et.al. 1996). Sex 
chromosomes are designated W and Z, hens carrying WZ and roosters carrying ZZ. In the chicken 
genome, there is only a very small amount of repetitive DNA  sequences compared to mammalian 
DNA, and there is also only a very  low number of pseudogenes. Also, a wide range of single 
nucleotide polymorphisms has been found in the chicken (Burt, 2007).
Unlike the viviparous mammals, the chicken is an oviparous (egg-laying) organism. Because of the 
fact that embryos grow in eggs outside the mothers’ body, the embryos’ energy supply  must be 
ensured before the egg is laid. This happens by incorporation of energy-rich molecules into a special 
compartment of the egg, the yolk. Yolk consists mainly of Vitellogenin and VLDLs (very low density 
lipoproteins). These molecules are transported into the yolk during follicle development via 
receptor-mediated endocytosis. The receptor necessary  for the internalization of VLDLs and 
vitellogenin into the yolk  is a member of the LDL receptor family, and is termed LR8, as it contains 
eight binding motifs rich in cystein residues.
In the laying hen, each day one oocyte enters a developmental cycle, gets enriched in yolk 
components and finally  ovulates. The major developmental stages in follicle development are the 
small white and large white follicle, the small and large yellow follicle and follicles F5, F4, F3, F2 and 
F1, with F1 being the next follicle to ovulate. 
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Figure 1.1 Stages of chicken follice development, SWF = small white follicle; LYF = large yellow follicle
In the Restricted Ovulator (R/O) chicken strain, a naturally  occurring infertile mutant, LR8, a 
95kDa receptor needed for the transport of yolk components into the yolk, is unfunctional 
because of a mutation in an EGF repeat, where a cystein is substituted for a serine residue 
(Bujo et.al.1995). Because of this, yolk precursors are not transported into the developing 
oocytes, the oocytes show an incomplete development and become necrotic before they can 
ovulate. Because the transport of yolk precursors into the oocytes does not work, R/O hens 
accumulate fat in their bodies, resulting in a hyperlipidaemic and potentially  atherosclerotic 
phenotype. The accumulation of fat is especially drastic in the liver which becomes 
ryellowish because of the high fat content.  Roosters of the R/O chicken strain have a normal 
phenotype, although the gene defect is located on the Z chromosome (Bujo et.al. 1994). In 
fact, one would expect a severe phenotype in roosters who possess two Z chromosomes; 
however, the LR8 gene is is not expressed much in other cells than oocytes, and therefore 
roosters are not affected by the mutation in the LR8 gene.
Figure 1.2 White leghorn hen (a) Healthy chicken liver (b) and chicken liver with fat accumulation (c) 
(a)  from http://www.moorlandspoultry.co.uk/white-star.html
(b)  and (c) adapted from http://www.seriouseats.com/recipes/images/liver%20on%20board%201.jpg
The hyperlipidaemic phenotype of the R/O hens offers a range of possibilities to investigate 
differential gene expression in various tissues, and so the chicken serves as an appropriate 
model organism for the aims of my diploma thesis.
F1 F2
F3
F4
LYF
SWF
F5
 
a)  b)  c)  
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1.2 The Lipid droplet as a complex organelle 
Organisms have the ability to store excess nutritional  energy that is not needed at the 
moment in special storage forms in certain tissues. Triacylglycerols (TG) are the main 
storage form of fat in adipose tissue. But apart from the storage of fat in adipocytes, 
eukaryotic  cells are also capable of storing a limited amount of neutral fat in so-called lipid 
droplets within the cytosol. In animal cells lipid droplets are sometimes also called 
adiposomes, and in plant cells they are referred to as oil bodies. In former times lipid 
droplets weren’t paid too much attention to, but in the meantime they are regarded as 
dynamic organelles resembling lipoproteins.
Like lipoproteins, lipid droplets have a core that contains TG and cholesterol esters (CE) and 
are – in contrast to vesicles - surrounded by a phospholipids monolayer that is coated with 
specific proteins.
Figure 1.3 Lipid droplet, PAT proteins associated to the phospholipid monolayer are shown in pink, green 
and blue. (adapted from Fujiomoto et al. 2008).
Although the energy store provided by lipid droplets is small, it is nevertheless important: the 
stored lipids can serve as substrates for the biosynthesis of membrane phospholipids, the 
products of TAG hydrolysis may affect cell signalling or gene expression by acting as ligands 
for certain receptors, on the cell surface or the nucleus, respectively. 
As already mentioned, like lipoproteins, lipid droplets are coated, and thereby also regulated, 
by a certain family of proteins, the perilipin family of proteins, also called PAT-proteins (the 
abbreviation PAT is derived from the first identified members of the perilipin family, Perilipin A, 
Adipophilin and TIP47).  
Some perilipin family members are always found on the surface of lipid droplets, others only 
under lipogenic/lipolytic conditions, so it appears likely that they regulate the packing and the 
transport of lipid droplets and their metabolites.  
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To date, there are five important known members of the perilipin family: Perilipin A (and its 
shorter isoforms B and C), Adipophilin, TIP47, OXPAT, and S3-12. Although they belong to the 
same protein family they do not share many structural features.
 
Figure 1.4  Perilipin family members and structure The mouse perilipin  family members are depicted. A 
faint colour represents  less sequence similarity  and stronger colour higher similarity of sequences. (from: 
Brasaemle,  2007)
In Figure 1.4 one can see that adipophilin, TIP47 and OXPAT are closer related to one another 
than to perilipin. S3-12 is missing a lot of features that are provided in the other family members. 
Except S3-12, all  family members contain a PAT  domain (green) at the N-terminus, consisting of 
about 100 amino acids that are highly conserved. The function of the PAT domain is not known.
An 11-mer repeat region (yellow) of variable size overlaps with the PAT domain and is also 
present in S3-12. The 11-mer repeat region is predicted to fold into amphipathic helices. 
There is contradicting data on wether or not the 11-mer repeat sequences are necessary for 
targeting the protein to the nascent lipid droplet (Yamaguchi et. al. 2006; Ohsaki  et. al. 2006, 
Garcia et. al  2003). Anyhow the amphipathic  helices seem to be necessary to place the protein 
on the lipid droplet in a distinct manner so that it performs its function optimally.
Following the 11-mer repeat region in TIP47, there is a 4-helix bundle region (blue) that also 
forms amphipathic helices. This region in TIP47 obviously provides stability to the protein both 
in the cytosol  and when bound to the lipid droplet (Wolins et al. 2001); furthermore the region 
also resembles the 4-helix bundle region on the N terminus of ApoE that is also exchangeable 
between lipoproteins and the blood (Hatters et al.2006). Although adipophilin shares high 
sequence similarity in this 4-helix bundle region, it doesn’t share the ambiguous state of TIP47 
as adipophilin was shown to be highly unstable in the cytoplasm (Xu et. al. 2005). 
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OXPAT, that is also closely related to TIP47 and adipophilin, also has the 4-helix bundle region, 
appears to be stable in the cytoplasm, but becomes rapidly recruited to nascent lipid droplets 
(Wolins et al. 2006). Adipophilin, TIP47, OXPAT, and S3-12 share one region of 14 amino acids 
that is not found in the sequence of perilipin A, which folds into an hydrophobic cleft (red). 
Perilipin A has some unique structural features among the family members: instead of the 4-
heilix bundle region and the hydrophobic  cleft region, it contains three hydrophobic regions 
(purple) interspaced by a strongly acidic region (turquoise). Additionally, Perilipin A is the only 
family member that contains consensus sites for phosphorylation by Protein Kinase A (PKA).
Perilipin A Adipophilin TIP47 OXPAT S3-12
Localized to 
Lipid droplet
constitutive constitutive transient transient transient
Cytoplasmic 
stability
instable instable stable stable instable
PKA sites 6 none none none none
Tissue 
distribution
White and 
brown adipose
tissue
All tissues 
except 
adipocytes
All tissues         heart
White 
adipocytes
            Table 1.1 Summary of characteristics of Perilipin family members
It is unclear how exactly lipid droplets are formed within the cell. The generally proposed model 
is that they emerge from the endoplasmic  reticulum (ER) by “budding” from the ER membrane 
to form a droplet. This is quite probable, as ER proteins have been found to be present in lipid 
droplets isolated from various cell types, e.g. 3T3-L1 adipocytes (Wolins et. al. 2005).
It is tempting to suggest that the lipid droplet formation takes place at the ER, because this is 
also the place where lipases that mobilize the energy from the lipid droplets are found. But it 
was also shown by cryo-electron microscopy that the fatty acid composition of the lipid droplet 
membrane differed from that of the phospholipids of the rough ER (Tauchi-Sato et. al. 2002). 
These data suggest that lipid droplets probably are synthesized in a different manner; 
nevertheless, the model of emergence from the ER today is the prevailing one.
Lipid droplets in the cell  usually aren’t uniform, but a heterogeneous pool in respect to their 
different size, localization, and protein coating. For example, under resting conditions, most 
droplets are coated with perilipin A and centrally located in the cell. When there is an influx of 
fatty acids into the cell, at the periphery a new pool of smaller droplets forms that are coated 
with S3-12 and TIP47. Over time, they “mature”, become larger and acquire adipophilin on their 
surface (Wolins et. al. 2006). 
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Whether differently coated lipid droplets also serve for different specialized functions in energy 
storage and metabolism remains to be elucidated. However, perilipin A - the best characterized 
family member of perilipin proteins - was found to play an important role in lipolysis, as later 
described in 1.4.4. 
1.3 Lipid trafficking: a brief overview
Dietary lipids and cholesterol that are taken up have to be distributed from the gastro-intestinal 
tract to different peripheral  tissues where they are needed for energy supply or biosynthesis of, 
e.g., steroid hormones or membrane lipids. Excess lipids are stored in the adipose tissue for 
times of energy scarcity.  Lipids are stored as triacylglycerols (TG) in the body.                              
There is one major problem that the body has to overcome to transport and store TG in the 
adipose tissue, namely the hydrophobicity of the TG and the polarity of the blood. Blood is an 
aequous liquid, whereas TG are lipophil, so TG can’t be transported as such within the blood 
stream. Instead, TG have to be packed in some sort of transport vehicle, the so-called 
lipoproteins. Lipoproteins are made up of a core containing TG and cholesterol esters (CE) and 
a monolayer of phospholipids that associates with apolipoproteins. Apolipoproteins have a 
structure containing amphiphilic helices that can integrate between phospholipids, thereby 
making the lipoproteins more soluble in the aqueous milieu. So apoproteins and phospholipids 
form a kind of amphiphilic  interface, whereas the core with the TG and CE is lipophilic. The 
amphiphilic interface enables the particle to be transported within the blood.
There are four types of lipoprotein particles: Chylomicrons, very low density lipoproteins (VLDL), 
low density lipoproteins (LDL), and high density lipoproteins (HDL). There are also different 
forms of apolipoproteins, namely ApoA1 and ApoA2, ApoB100 and ApoB48 (a truncated form of 
ApoB100), ApoC and ApoE. The major characteristics of lipoprotein particles are listed in Table 
1.2.
   INTRODUCTION_____________________________________________________________________
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Chylomicrones VLDL LDL HDL
Density [g/ml] <0,95 0,95-1,006 1,019-1,063 1,063-1,21
Size [nm] 100-1000 50 20 10nm
Content
85% TG
15% Protein
50% TG
20%Phospholipid
10% CE
10% Protein
40% CE
20% Protein
20%Phospholipid
10%TG
50%Protein
25%Phospholipid
15% CE
Proteins ApoB48; E; C ApoC; B100; E ApoB100 ApoC; A;E
Built in Colon Liver Liver Liver
Function
Transport of TG 
and Cholesterol to 
the periphery
Transport of TG 
to peripheral 
tissue
Transport of CE 
to the liver and 
periphery
reverse 
cholesterol 
transport 
Half life 5min 3hours 2,5 days 3,5 days
         Table 1.2 Characteristics of Apolipopoteins (from Horn et al. 2005; Löffler 2001)
           How does the packing into lipoproteins work? 
Dietary TG are metabolised in the gastro-intestinal  tract. In the gut they are broken up into 
monoacyl-glyerol and two fatty acids. These single components are lipophilic and small enough 
to be taken up via diffusion by the enterocytes. In the enterocytes they are rebuilt to TG and 
then together with CE, phospholipids and apoproteins they become assembled as 
chylomicrons. Chylomicrons are the largest lipoprotein particles, as they contain a huge amount 
of TG and CE.  The chylomicrons are released into the lymph to avoid the storage of their TG 
and CE in the liver, enter the blood stream at the ductus thoracicus, and supply peripheral 
tissues with their load. .
The chylomicrons then reach the liver as chylomicron remnants containing little TG. In the liver, 
in the postprandial  period, VLDLs are synthezised. VLDLs are smaller than chylomicrons 
because they contain less TG and have a composition of apoproteins different from 
chylomicrons. VLDLs travel  to the periphery and supply tissues, especially the adipose tissue, 
with TG and CE.  As in the case for the concersion of chylomicrons to chylomicron remnants, a 
special extracellular lipase is needed, i.e. lipoprotein lipase (LPL). This lipase is attached to 
endothelial cells of blood vessels, and has a high affinity for both chylomicrones and VLDLs and 
needs ApoC-II on lipoprotein particles as a co-factor. In the presence of insulin (after food 
consumption) LPL becomes active and starts to act on lipoproteins in the circulation. LPL 
cleaves TG into monoacylglycerol and free fatty acids that can be taken up into cells where they 
are then re-built to TG. By giving off TG to peripheral tissues, VLDLs diminish in size and 
become LDLs, which contain mainly cholesterylesters in their core. 
LDL particles are taken up by cells by receptor-mediated endocytosis via LDL receptors. When 
cholesterol enters the cell, a feedback loop stops the cells’ own cholesterol production and 
instead the cell uses the cholesterol delivered from the LDL particle.
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Figure 1.5 The LDL particle, The relatively big ApoB100 protein (yellow) is associated with the surface 
consisting of phospholipids (turquoise) and unesterified cholesterol  (orange). The core consists of cholesteryl 
esters  and a small  amount of TG.The phospholipid layer is only a monolayer.From:http://
foodspace.files.wordpress.com/2008/05/ldl.jpg
The LDL concentration in the blood is associated with an increased risk for arteriosclerosis.  If 
the LDL concentration in the blood is increased due to limited clearance of LDL from the blood, 
the LDL particles become oxidized and attach to the intima of blood vessels. Macrophages 
recognize oxidized LDL but not via the LDL receptor.
Instead they recognize LDL with (a) so-called scavenger receptor(s).  Because of this, there is 
no feedback loop to stop the macrophages’ cholesterol production and the cells accumulate 
cholesterol, becoming  so-called “foam cells”. Foam cells form plaques within the blood vessel 
and clog the vessel, thereby blocking the blood flow and increasing the risk of a heart attack.
Although every cell is capable of synthezising cholesterol, all cells lack mechanisms to degrade 
cholesterol. There are only two ways to eliminate cholesterol from the organism: by scaling off 
mucosa cells containing cholesterol from the colon and export them with the feces or by forming 
bile acid from cholesterol. HDL particles are in permanent contact with other lipoproteins and 
can take up TG, phospholipids, and cholesterol esters from chylomicrons and VLDL and either 
redistribute them to other lipoprotein particles or to tissues in need of cholesterol for biosynthetic 
processes. They are also able to eliminate cholesterol  from macrophagic plaques, which is why 
HDL is commonly referred to as “the good cholesterol” (Horn et al. 2005).
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1.4 Energy Homoestasis: Lipogenesis and Lipolysis
Although most people would say that fat is not healthy for the body, a certain amount of fat is 
essential for our survival. Lipids supply our bodies with energy, and they are especially 
important, as the major component of every cell  membrane are (phospho-)lipids which surround 
the cells in bilayers. Adipose tissue also serves as an endocrine organ and is able to produce 
and secrete endo- and paracrine factors, the so-called adipokines (e.g. leptin), which modulate 
e.g. insulin sensitivity.  
Our body has the ability to synthezise, break down, and store fatty acids. The body stores fat in 
times of plenty in the adipose tissue and breaks it down in times of fasting to gain energy in the 
form of ATP for the body. TG are the major storage form of fat in the body. They are made up of 
four single components, a glycerol  molecule and three fatty acid molecules. TG are more 
energy-rich molecules than carbohydrates, and so they form a perfect energy depot.  
The biosynthesis of TG is called lipogenesis, the degradation of TG to gain energy is generally 
called lipolysis. Whether the body performs lipogenesis or lipolysis is dependent on the supply 
with energy, i.e. food, and on hormones. Insulin, the hormone emitted after a meal to lower the 
blood glucose level  again, activates lipogenesis so that fats are stored in the adipose tissue. 
Glucagon, the antagonist of insulin, and adrenalin, emitted under stress when more energy is 
needed, activate lipolysis so that energy is produced by the breakdown of TG (β-Oxidation of 
fatty acids).
As metabolic  diseases related to aberrations in energy homeostasis, such as obesity, diabetes, 
the metabolic syndrome, arteriosclerosis, and heart attacks are a growing problem in the 
Western world, it is crucial to understand the underlying regulating mechanisms and to 
investigate the interactions between molecules involved in lipid metabolism for a better 
understanding of lipid metabolism forwards new therapeutic possibilities.
One group of enzymes that is crucial to regulate lipolysis are the lipases. Key lipases are 
discussed in the following sections.
1.4.1 Hormone sensitive Lipase (HSL)
The fasting body has to mobilize its energy stores for necessary metabolic  processes. To gain 
energy the body fat stores can be broken down by lipases. Among the lipases, those that cleave 
TG, DG, or MG depending on their affinities for these substrates are an important group In 
different tissues, different lipases are present. In adipose tissue, it was thought for a long time 
that the hormone-sensitive lipase (HSL) was the most important lipase catalyzing lipolytic 
reactions. Apart from its high expression in adipose tissue, HSL is also present in ovary, testis, 
and adrenal, reflecting the fact that adipose tissue and its proteins also serve a role as 
endocrine organ.
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Surprisingly, HSL seems not to be related to any other mammalian lipase known, but shares 
noticeable sequence homology with a lipase of an antarctic bacterium, Moraxella TA144 (Feller 
et al 1991, Langin et al. 1993). 
HSL is a serine hydrolase with the catalytic Serine residue found in the characteristic  lipase 
motif G-X-S-X-G (Holm et al. 1994). The Serine residue together with Aspartic  Acid and 
Histidine builds a classic Ser-Asp-His catalytic  triad (Osterlund, et al. 1997). The multi-domain 
structure that is proposed for HSL due to sequence and molecular modeling analysis (Osterlund 
et al. 1997; Smith et al. 1996) is depicted in Figure 1.6. The N-terminal  site of HSL is now 
proposed as a binding domain for HSL interaction partners and comprises about 300 amino acid 
residues that are variable. The C-terminal  domain is the catalytically active site of about 400 
amino acid residues, making up 48kDa. The C-terminal  domain also contains a regulatory 
module necessary for activation of HSL by Protein Kinase A. In its functional form HSL acts as a 
dimer, although HSL monomers also exhibit enzymatic activity (Shen et al. 2000). 
Figure 1.6 HSL multi-domain structure (from Yeaman 2004), in (A) the gene structure (intron/exon 
organization) is depicted, three different  ATG start codons result in three possible isoforms of HSL that 
have different size. (B) represents the primary  protein structure, yellow being the N-terminal domain, the 
C-terminal domain is coloured in blue with the regulatory domain for PKA in green. (C) shows the 
proposed domain-structure, the colour code is the same as in (B). 
As one can see in Figure 1.6, there are three ATG (AUG, respectively, in the mRNA) start 
codons, resulting in three different isoforms of HSL, that range in their size from 84kDa to 
130kDa (Holm et al. 1988). 
As already mentioned, HSL action is controlled by phosphorylation by PKA. If a lipolytic signal is 
received by the cell, such as docking of catecholamine (or ACTH, glucagon, noradrenalin or 
adrenalin) to a β-adrenergic  receptor, conversion of ATP to cAMP by adenylate cyclase occurs. 
Increased cAMP levels in the cell  activate Protein Kinase A (PKA) which in turn phosphorylates 
HSL to activate it. The phosphorylation of HSL results in a 2-fold increase of HSL activity - 
however, lipolytic  rates increase by 100-fold in the adipose tissue in response to lipolytic  stimuli 
(Nilsson et al. 1980, Londos et al. 1985).  Therefore, it was supposed that the phosphorylation 
of HSL could not be the only step necessary for effective lipolysis. 
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The discovery that perilipin, a lipid droplet associated protein (Greenberg et al. 1991; also see 
1.2), is also regulated in its action by phosphorylation by PKA, finally answered the question 
why HSL activity after phosphorylation only increased slightly, while lipolytic rates increased 
massively. It was found that perilipin associates with lipid droplets only under unstimulated basal 
conditions, but dissociates from the lipid droplet upon hormonal  stimulation, thereby providing 
free access for HSL to the lipid droplet surface.  Concluding, the phosphorylation of HSL and 
perilipin by PKA results not only in activation of HSL but also in translocation of HSL from the 
cytosol to the lipid droplet (Su et al. 2003; Sztalryd et al. 2003). This is schematically shown in 
Figure 1.7.
Figure 1.7 Activation of  HSL and perilipin by PKA, under basal  conditions, HSL is located in the 
cytoplasma and perlipin is bound to the lipid droplet, both proteins  are dephosphorylated. Upon a lipolytic 
stimulus, PKA becomes activated by an increase of the intracellular cAMP  concentration, and 
phosphorylates both HSL and perilipin – perilipin dissociates from the lipid  droplet, giving way for HSL 
action on the lipid droplet surface.  (© Carolin Besenböck)
Furthermore HSL may be activated by the MAPK (mitogen activated proteins kinase) pathway 
by the MAPK ERK. There are 4 phosphorylation sites for ERK present in the HSL molecule and 
ERK, as PKA, is able to increase the activity of HSL about 2-fold (Greenberg et al. 2001). 
However, the physiological relevance of ERK signaling on HSL activity is not yet well 
understood.
At the beginning of the new millennium, some groups succeeded in generating HSL knock- out 
mice. These mice showed a surprising phenotype. It was expected that mice lacking HSL would 
present massive TG accumulation in the plasma and organs, and would be obese. In fact 
HSL-/- mice were quite lean and did not show TG but DG accumulation in adipose tissue, 
muscle, and testis (Wang et al. 2001; Haemmerle et al 2002).  Male HSL-/- mice were sterile 
due to oligospermia (Osuga et al. 2000), but the molecular mechanism underlying the 
development of sterility in HSL knock-out mice is not understood. 
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The observation that HSL- deficient mice did not accumulate TG but DG led to the proposal that 
not HSL was in fact the prime lipase of adipose tissue, but a DG lipase that would have to act in 
concert with a TG lipase for effective lipid breakdown. This TG lipase was demonstrated to be 
ATGL and is further discussed in 1.4.2.
HSL has a number of interaction partners, two of which are of interest for this work and shall  be 
further discussed here. As the exact function of the HSL N-terminus was not yet characterized, it 
was supposed that it may serve as binding site for interaction partners of HSL. In 1999, Shen 
and colleagues could show that HSL is interacting with FABP4 (fatty acid binding protein 4; also 
adipocyte lipid binding protein, ALBP) and that this interaction is dependent on an intact N-
terminal region (Shen et al. 1999). 
Fatty acid binding proteins are single-chain polypeptides of low molecular weight (approx. 
15kDa). They usually form complexes with fatty acids in a 1:1 stoichiometry (Bernlohr et al. 
1997) and facilitate their diffusion between different cell compartments (Shen et al. 2001). 
It has been shown that lipid binding proteins form barrels and sequester fatty acids from the 
cytosol by taking them up into the cavity of this barrel. From their observations, Shen and 
colleagues proposed a model of interaction for FABP4 and HSL, where FABP4 is bound to the 
HSL N-terminal  region in the basal state and dissociates from it when HSL actively cleaves its 
substrates to produce fatty acids that are then sequestered by FABP4, possibly resulting an 
facilitated efflux of fatty acids from the cell  (Shen et al. 1999). It was also proposed, that the 
binding of fatty acids by FABP4 prevents HSL from self-inhibition via feedback mechanisms. 
Furthermore, the group showed that co-expression of FABP4 and HSL in CHO cells increases 
lipolysis by 50%.
A second protein that was shown to interact with HSL is StAR (steroidogenic  acute regulatory 
protein).  StAR actually serves as a mitochondrial  cholesterol  transporter which transduces 
cytosolic cholesterol from the outer mitochondrial  membrane (OMM) to the inner mitochondrial 
membrane (IMM) where the cholesterol  is converted into pregnenolone by P450scc, the 
cholesterol side chain cleavage enzyme – which is the first and rate limiting step in steroid 
hormone biosynthesis.  StAR is produced as a 37kDa precursor protein that is then cleaved to a 
30kDa mature protein (Stocco et al. 1991). It is well conserved among different species, such as 
mammals, birds and amphibians (Bauer et al. 2000). It is mostly expressed in the adrenal 
cortex, in steroidogenic  cells of ovary and testis, and to some extent also in the brain (Sugawara 
et al 1997).
The StAR protein has a quite unique sequence; its structure contains 2 long α- helices at the N- 
and the C-terminus, and two α-helices that together with nine antiparallel β-sheets form an α-/β 
fold. Most strikingly there is a hydrophobic pocket that provides exactly the dimensions needed 
to take up a single cholesterol molecule (Murcia et al. 2006). 
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As the protein is also stable and fully active in the cytoplasm and its half-life of 15-60min is 
much longer then needed for an acute steroidogenic  response, it was proposed that the protein 
probably serves more functions than known to date.
HSL is a lipase that is abundant not only in adipose tissue, but also in steroidogenic tissues. 
HSL and StAR are both expressed in rodent adrenals. Interestingly, both proteins are also 
activated in the same manner: as described previously, HSL is activated by PKA as a result of 
ligand binding to a G protein coupled receptor and the subsequent increase of cAMP levels. The 
same is true for StAR: it is activated by PKA, and PKA was shown to be essential  for StAR 
steady state levels (Manna et al. 2005). 
Shen and colleagues performed GST-pull down experiments with HSL and StAR from adrenals 
isolated after StAR expression was induced with ACTH (Shen et al. 2003). The group also 
performed mutational  studies and found that the sites needed for HSL and StAR interaction, 
which are the first 62 n-terminal amino acids and a region between amino acid residue 180 and 
221 of StAR. 
Co-expression of StAR and HSL in hamster ovary cells resulted in an approximately 75% 
increased level  of hydrolysis of cholesteryl ester substrates, indicating that StAR is able to 
modulate HSL activity. 
Unlike FABP4, StAR has no lipid binding properties – StAR may affect HSL action by altering 
HSL conformation to allow better substrate access or may prevents free fatty acids from 
inhibiting HSL. The interaction of StAR and HSL also has a positive effect on intracellular 
trafficking of cholesterol between compartments. The interaction of HSL and StAR was, 
however, only shown in adrenal cells and only for the StAR family member present there (StAR 
– also referred to as StarD1). 
However, there are other family members like StarD4 and StarD5 that are ubiquitously 
expressed in all tissues and may also interact with HSL. Therefore, further investigations of the 
StAR/HSL interaction are necessary.
1.4.2 Patatin-like Phospholipases
The so-called family of patatin-like phospholipases (PNPLAs) is a protein family that has quite 
recently been described to function in lipid metabolism. PNPLAs are derived from a common 
ancestor, the Patatin protein which was first identified in potato tubers. Patatin acts as a storage 
protein in potato tubers and makes up about 40% of the potatoes’ soluble proteins (Vancanneyt 
et al., 1989).  It also contains the consensus serine lipase motif G-X-S-X-G and acts as an acyl-
hydrolase.
After the identification of Patatin, Patatin-like phospholipase family members have been found 
and investigated, for example in yeast (Kurat et al. 2006) reflecting that the Patatin-like 
phospholipase family may play an important role in lipid metabolism and is therefore conserved 
from yeast over avian species to mammalians. 
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Characteristically all  Patatin family member proteins share the so-called Patatin domain (Pfam 
01734). All family members contain the G-X-S-X-G active site motif of lipases, but instead of 
general hydrolase activity some of the family members exhibit phospholipase activity.  
The Patatin-like phospholipase domain shows some characteristic features, such as a three-
layer α-β-α architecture, and instead of the typical  catalytic  triad, in Patatin proteins there is a 
catalytic dyad consisting of Serine and Aspartic Acid (see Fig. 1.8).
Protein folding produces a 3D arrangement that differs from other hydrolases, by placing the 
catalytic Serine into a nucleophilic bow and producing an oxyanion-hole that is thought to be 
able to stabilize the transition state of the enzyme-substrate complex (Rydel et al. 2003).
Figure 1.8 Patatin domain structure (PAT17); helices  are shown in blue, β-sheets are numbered and drawn 
in  pink, coils are depicted  in yellow. The active site Serine S77 and Aspartic Acid D215 are shown in  green 
(from Rydel, 2003). 
Apart from the highly conserved Patatin domain and certain hydrophobic  residues, the actual 
sequences do not share high sequence similarity within a species or between different species 
(Wilson et al. 2006; see Fig. 1.9).
Also, the tissue expression patterns vary much between different species - e.g. PNPLA3 in 
humans and the chicken is highly expressed in the liver, whereas in mice it has highest 
expression levels in adipose tissue.
In humans, nine Patatin-like phospholipase family members have been identified, which are 
designated PNPLA1-9; in our model organism, the chicken, there are known homologs to all 
human PNPLAs except for PNPLA5; in mice no homolog to human PNPLA4 is known. 
Characteristics of human PNPLA family members are listed in Table 1.3.
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As one can see from Table 1.3, little is known about Patatin-like phospholipases, especially the 
biochemical  functions of the various family members are unknown, although functions are 
suggested. It is also problematic that the enzymatic activities of most family members could only 
be shown in vitro, but in vivo often no such activities could be detected. It is known that many 
family members, such as PNPLA2, PNPLA3, PNPLA5 and PNPLA7 are regulated in 
accordance with the nutritional status (fasting, insulin signaling). 
The two best characterized patatin-like phospholipase family members, PNPLA2 and PNPLA3, 
are further described in the following sections.
Enzymatic 
Activity
Function Expressed in
Co-
activators
Cellular 
localization
PNPLA1 unknown unknown unknown unknown unknown
PNPLA2
Lipase, 
Transacylase
TG break-down
white adipose 
tissue
CGI-58 Lipid droplets
PNPLA3
Hydrolase, 
Transacylase
unclear adipocytes, liver unknown
Adipocyte 
membranes
PNPLA4
Retinol ester 
hydrolase
Epidermal 
morphogenesis?
muscle, liver, 
skin
unknown unknown
PNPLA5 TG hydrolase
Adipocyte 
differentiation?
lung, adipocytes unknown unknown
PNPLA6
Lysophospho-
lipase 
Maintenance of 
axon integrity
nervous system unknown ER and Golgi
PNPLA7
Lysophospho-
lipase
Adipocyte 
differentiation?
Prostate, 
pancreas
unknown
ER
Lipid droplets
PNPLA8 Phospholipase
Importance in 
mitochondria?
heart unknown
Mitochondria 
peroxisomes
PNPLA9 Phospholipase
Lipid 
remodelling
Cell signalling
ubiqitous unknown Cytoplasma
Table 1.3 Some characteristics of mammalian PNPLA family members (Kienesberger et 
al. 2008)
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1.4.2.1  ATGL (Adipocyte Triglyceride Lipase; PNPLA2)
To mobilize energy stored as TG in the adipose tissue in times of nutritional scarcity, the body is 
dependent on lipases that are able to break down TG to DG and further to MG, FFA and 
glycerol. For a long time it was believed that hormone-sensitive Lipase (HSL, see 1.4.1) was the 
only lipase present in adipose tissue to fulfill  this function. However, when HSL knock-out mice 
were generated, they did not show the expected obese phenotype and/or TG accumulation in 
the plasma at all (Wang et al. 2001, Zimmermann et al. 2004, Okazaki et al. 2002). Instead they 
showed massive accumulation of DG, thereby suggesting that there must be at least one 
additional  lipase present in the adipose tissue. Subsequently, ATGL was identified to be this 
additional  lipase in the adipose tissue (Zimmermann et al. 2004; Villena et al. 2004; Jenkins et 
al. 2004).
ATGL/PNPLA2 (also called Desnutrin) shares the classic  features common among all  Patatin-
like phospholipase (PNPLA) family members, such as the Patatin domain and the G-X-S-X-G 
lipase motif. The murine ATGL gene is highly expressed in white and brown adipose tissue and 
codes for a protein of 54kDa. Zimmermann et al. showed by transfection of COS-7 cells that 
ATGL is in fact a triglyceride lipase, which is, unlike HSL, unable to cleave cholesteryl- or retinyl 
esters. Finally ATGL knock-out mice showed the phenotype that was expected for HSL knock 
out mice, with massive accumulation of TG in white adipose tissue but also in non-adipose 
tissues (e.g the heart), giving rise to the conclusion that loss of ATGL function cannot be 
compensated by HSL function (Haemmerle et al. 2006). ATGL obviously has especially high 
affinity for TG substrates, and while HSL has TG lipase activity, its affinity for DG substrates is 
10-fold higher than for TG substrates (Frederikson et al. 1981). Therefore Zimmermann and 
colleagues proposed a model  in which ATGL is responsible for the first step of TG breakdown, 
the cleavage of TG to DG and one FFA, and HSL subsequently breaks down the resulting DG to 
MG and a second FFA (Zimmermann et al. 2004).
Whereas HSL is regulated by phosphorylation and de-phosphorylation in response to cAMP 
levels by Protein Kinase A (PKA), no activation of ATGL was observed upon phosphorylation by 
PKA. However, there is a connection between PKA signaling and ATGL activation – soon after 
ATGL had been identified, a regulatory protein interacting with ATGL, CGI-58 (comparative gene 
identification 58) was. To date, the exact mechanism of regulation of ATGL by CGI-58 is still not 
completely clear. However, it is known that in hormonally unstimulated cells, CGI-58 binds to 
perlipin, a major lipid droplet protein (see 1.2).
When cells were stimulated by a lipolytic  stimulus, such as catecholamine binding to an β-
adrenergic receptor on the cell, cAMP levels rise, activating PKA, which in turn phosphorylates 
perilipin. This phosphorylation results in the dissociation of CGI-58 from perilipin and its co-
localization with ATGL (Grannemann et al 2007). Mutations within the ATGL gene and within the 
CGI-58 gene have been discovered and shown to cause certain pathologies, so-called neutral 
lipid storage diseases, which indicates that these two proteins are crucial  for normal lipid 
metabolism.
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1.4.2.2 PNPLA3 (Adiponutrin)
PNPLA3, also called Adiponutrin, is another well-investigated member of the Patatin-like 
phospholipase family. The human PNPLA3 gene, located on chromosome 22, codes for a 
52kDa transmembrane protein. It is highly expressed in adipose tissue and in liver. The precise 
function of adiponutrin is unclear and there are contradicting data whether it acts as lipogenic or 
lipolytic  factor –although to some extent PNPLA3 has lipase activity in vitro, there are data 
showing that in vivo PNPLA3 does not exhibit lipase activity at all  (Zechner et al. 2005, Kershaw 
et al. 2006).
Within the patatin-like phospholipase family, PNPLA3 shares highest sequence identity with 
ATGL (PNPLA2). However, the expression pattern of PNPLA3 upon changes in the nutritional 
status of the cell  is the exact opposite of ATGL: the expression level  of PNPLA3 is known to 
decrease upon fasting and to increase upon refeeding (Baulande et al. 2001), suggesting that 
PNPLA3 rather acts as an anabolic enzyme. In humans, the expression of PNPLA3 mRNA is 
positively linked to obesity (Johannson et al. 2006) and is reduced if body weight is lost (Liu et 
al. 2004). It was also shown that, in humans, PNPLA3 expression is regulated by insulin and 
blood glucose levels, and that PNPLA3 expression differs in healthy humans and individuals 
suffering from Type 1 or Type 2 diabetes (Moldes et al. 2006).
It is known that many genes involved in lipid metabolism are regulated by synergistic action of 
the LXR (liver X receptor) and SREBP1-c  (sterol regulatory element binding protein 1-c): LXR 
agonists enhance the synthesis of fatty acids mainly by activating the gene for SREBP1-c, 
which then turns on many genes involved in lipogenic  actions (Liang et al. 2002, Chen et al.
2004).  Recently it was shown that also the PNPLA3 gene is, at the molecular level, regulated 
by a LXR/SREBP1-c synergy (Huang et al. 2010).  The group of Huang showed that mice 
overexpressing SREBP1-c had a 12-fold increase of PNPLA3 mRNA levels in the liver, 
suggesting a regulation of PNPLA3 by SREBP1-c. 
Treatment with an LXR agonist, T0901317, only had a positive effect on PNPLA3 mRNA levels 
if SREBP1-c was expressed, thus in srebp1-c-/- knock-out mice the LXR agonist had no effect, 
thereby indicating that the increased expression of PNPLA3 is not a result of a direct action of 
LXR, but is dependent both on LXR and SREBP1-c.
The investigations of the PNPLA3 gene gained even more isignificance when a single 
nucleotide polymorphism within the PNPLA3 gene associated with non-alcoholic  fatty liver 
disease, was identified (Romeo et al. 2008, Kotronen et al. 2009). Non-alcoholic fatty liver 
disease (NAFLD) is the most common pathologic  condition of the liver in the Western World. 
NAFLD can occur in different grades of severity, ranging from an increased excessive storage of 
fat in the liver (hepatic steatosis), liver inflammation, or cirrhosis that can lead to hepatic cancer 
(Browning et al. 2004) – these symptoms are, however, not caused by alcohol abuse or other 
life style-related factors. Also the high liver fat content is not related to a high BMI or general 
obesity. It is estimated that about 10% of all liver transplantations performed are due to cirrhosis 
as a result of NAFLD (de Alwis et al. 2008). 
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It had been observed that in the United States, different ethnics group such as Hispanics, 
African-Americans and Caucasians have a different predisposition to develop non-alcoholic  fatty 
liver disease. Based on this observation, Romeo et al. performed a genome-wide association 
scan of nonsynonymous sequence variations and found that an allele of PNPLA3 that carried a 
SNP was strongly associated with liver fat content (Romeo et al. 2008). 
The SNP substitutes a cytosine for a guandine in codon 148 resulting in a change from 
isoleucine to methionine. The isoleucine residue at position 148 is very well conserved among 
different species (see Figure 1.10) and therefore may be crucial for PNPLA3 function.
Figure 1.10 Conservation of  Isoleucine 148 in PNPLA3 among different species (adapted from 
Kotronen et al. 2009). Chicken protein sequence was obtained from NCBI Gen Bank (EU419875.1) and 
aligned with the human residues 141-155 shown here using ClustalW2. The N-Terminus  of ggPNPLA3    is 
still unknown, therefore residues are numbered 67-82. Like in the Frog, the important  residue here is a 
Valine instead of Isoleucine.
Romeo and colleagues showed that the I148M allele of the PNPLA3 gene is very common in 
Hispanics, the ethnic group having the greatest risk to develop NAFLD and the highest liver fat 
content. In African-Americans, the group with the least prevalence for developing NAFLD, 
another allele – S453I – was found which seems to be associated with especially low liver fat 
content. Moreover, in people carrying the I148M allele the plasma levels of two liver enzymes 
(ALT and AST) which are responsible for liver inflammation were elevated, thereby suggesting 
that PNPLA3 plays a role in liver inflammation. Interestingly, there was no association between 
the SNP and BMI, insulin resistance, or plasma TG and LDL levels. A European group later 
showed that the observations of Romeo et al. were also true for European populations 
(Kotronen et al. 2009).
Although the PNPLA3 gene is well investigated and it is now known how PNPLA3 is regulated 
and that there are pathologies associated with PNPLA3 mutations, the exact function of 
PNPLA3 remains unclear and further research is required.
67-ALICSSFVPIYCGLI-82 Chicken
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1.4.3 Arylacetamide Deacteylase (AADA)
Arylamines and heterocyclic amines are carcinogens that need to be eliminated from the cell. 
For this the cell  employs certain enzymes. The principal  detoxifying enzyme is arylamine N-
transferase (NAT) that competes with CYP1A2 (a member of the cytochrome P450 family) for 
the primary arylamine substrate.  Arylacetamide deacetylases are capable of converting the 
arylacetamide back into a primary arylamide, thereby making it available for NAT. Therefore, 
arylacetamide deacteylases are proposed to be detoxifying enzymes necessary to degrade 
carcinogens (Satoh, 1987).  Human AADA is a 45kDa protein present in high amounts in liver, 
small intestine, and kidney, tissues susceptible to cancerogenesis, which need high amounts 
of detoxifying enzymes.
While lipases of adipose tissue are well  known and characterized, it is still unclear if there are 
hepatic lipases promoting β-oxidation and thereby energy generation from TG stores. 
However, in the 1990’s Probst et al. identified liver arylacetamide deactelyase also as an 
esterase in addition to its detoxifying activity (Probst et al. 1991 and 1994). 
When the AADA amino acid sequence is aligned with different eukaryotic  and prokaryotic 
esterases, it shows highest identity with Moraxella TA 144 lipase 2 and hormone-sensiive 
lipase. HSL is thought to be related to Moraxella lipase 2, but AADA shows even higher 
sequence similarity to this enzyme than HSL itself.
Moraxella 
TA144
G A S P S R I V L S G D S A G G C L A A L V A Q Q
Hs AADA G V N P E R I G I S G D S A G G N L A A A V T Q Q
Hs HSL G S T G E R I C L A G D S A G G N L C F T V A L R
Figure 1.12 Alignment of the AADA active site motif with Moraxella lipase 2 and HSL; all lipases 
show the same active site motif G-D-S-A-G. 
Apart from the aligned sequences of the active site motifs shown in Figure 1.12, AADA has 
another interesting region that appears to by closely related to HSL (42%): it starts at Arg104, 
contains the active site serine, and ends at Tyr216. This stretch contains the dipeptide His-
Gly112 which is thought to be necessary for the binding of lipids to HSL (van Oort et. al. 1989). 
Another region that shows 40% identity is located on the C-terminal part of AADA (Val317 to 
Leu381). In human HSL this region is required for hormonal  control, and converts HSL into its 
active form when cAMP signalling occurs (Langin et al. 1993). However, in AADA this hormonal 
control  region is not found in this stretch, raising the possibilty that AADA is not hormonally 
controlled.
The sequence similarity in important regions required for lipolytic activity suggests that AADA 
has more functions than known. In fact, in lipase and esterase assays, AADA could be shown to 
exhibit esterase activity: pNitrophenylacetate (pNP) and 4-Methylumbelliferylheptanoate (4-
MUH) were used as substrates to monitor hydrolytic activity of AADA, which exhibited activity 
against these lipid esters (Lo et al. 2010). 
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Cells stably expressing AADA contained significantly less TG than control  cells. These 
differences were abolished when E600, a lipase inhibitor, was added to the cells. If E600 was 
removed again, the preformed TG was turned-over rapidly again in both AADA and control cells, 
indicating that AADA does not take part in TG hydrolysis (Lo et al. 2010).  There was also no 
activity against cholesterol esters.  As AADA was shown to be located in the ER, Lo and 
colleagues proposed a model  for AADA activity in which AADA exhibits activity against 
endogenous DG synthetisized in the ER compartment, whereas TG stores in lipid droplets are 
not accessible for AADA.
Many genes in lipid metabolism are regulated diurnally according to the food intake over a 24 
hour cycle. AADA was shown to be expressed in such a diurnal pattern, with the highest 
expression in the post-absorptive phase. This pattern resembles the pattern of VLDL secretion. 
As VLDL secretion is dependent on a cycle of lipolysis and re-esterification of TG, AADA might 
support hepatic  fuel homeostasis (Trickett et a., 2001). This is also consistent with the model 
proposed by Lo et al., as fatty acid release in the ER could result in re-esterification of lipolytic 
products by ER resident acyltransferases such as AADA, thereby supporting VLDL production.
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1.5 Aims of the Thesis
In my diploma thesis I had two more or less independent projects: one was the characterization 
of PNPLA3 in the chicken, the other was the quest for a chicken analog of HSL.
In our model organism, the domesticated chicken Gallus gallus domesticus, the tissue distribution 
and expression patterns of the different Patatin-like Phospholipase family members have already 
been investigated (Saarela et al. 2008) when I started my diploma thesis. PNPLA3 expression 
was shown to be especially high in skeletal muscle, liver, and testis, resembling the human 
expression pattern with high expression in liver, muscle, and adipose tissue rather than, for 
example, that of mice (Lake et al. 2005). Therefore, and for reasons mentioned in 1.1, the 
chicken appeared to be a good model  to study PNPLA3 function. I wanted to investigate changes 
in PNPLA3 expression under a variety of conditions in wild type and mutant animals not only at 
the mRNA level, as it had been done before, but also at the protein level. For this I needed to 
raise an antibody against ggPNPLA3. Cloning and generating this antibody was a major part of 
my work. With the antibody, I was then also able to monitor the translational state of PNPLA3 in 
various tissues and under different conditions, obtaining insight into its regulation and 
physiological role(s).
Interestingly, although it is known that there is DG breakdown in the chicken, the enzyme 
performing this step is unknown. In mammals the enzyme necessary for this is HSL; in chicken, 
however, a homologue of HSL has not been identified. Since AADA was shown to share 
sequence homology with HSL in rodents and mammals, we hypothesized that AADA may take 
over the function of HSL in the chicken. It was shown that HSL interacts at least in vitro with StAR 
(see 1.4.1), a protein involved in steroidogenesis; therefore I cloned ggStAR and expressed it 
recombinantly to test whether StAR would also interact with AADA. I also tried to determine if 
there were AADA isoforms that are mainly expressed in fat tissue, because an analogue of HSL 
should be present predominantly in adipose tissue. Furthermore, I tried to show that AADA has 
not only esterase, but also lipase activity.
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2. Materials and Methods
2.1 Chemicals and Enzymes
Chemicals that were used for the production of solutions and buffers were purchased from 
Amersham Bioscience, Amresco, AppliChem, Fluka, Merck, Roth, Sigma-Aldrich and Star 
Lab.
Enzymes used for restriction digests were obtained from Fermentas or Promega.
Polymerases used were High Fidelity PCR Mix by Fermentas and High Velocity DNA 
Polymerase by Bioline. Additionally for RT-PCR either LightCycler® 480 SYBR Green I 
Master by Roche or KAPA SYBR FAST qPCR LightCycler480 by PeqLab were used.
Furthermore DNase I and Superscript® II Reverse Transcriptase, both by Invitrogen, were 
used for cDNA production.
Protein markers were obtained from Bio-Rad, DNA markers were bought from Fermentas.
2.2 Bacterial Strains and Vector Systems
Strain One Shot TOP10 Chemically Competent E.Coli
Genotype
F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 
araD139 ∆(ara- leu)7697 galU galK rpsL (StrR) endA1 nupG
Reference/Source Invitrogen
Table 2.1 Bacterial Strain used for transformation
Strain One Shot BL21 (DE3)
Genotype                          F- ompT hsdSB (rB-mB-) gal dcm (DE3)
Reference/Source Invitrogen
Table 2.2 Bacterial Strain used for expression of recombinant proteins
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Vector TOPO TA Vector
Size 3931bp
Genotype
LacZα, M13 reverse priming site, MCS, 
T7 promotor/primer, M13 forward priming site, f1 origin, KanR ORF, 
AmpR ORF, pUC origin
Reference/Source Invitrogen, TOPO TA Kloning Kit
Table 2.3 Cloning and sequencing vector
Figure 2.1 TOPO vector map
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Vector pBluescript SK+
Size 3kb
Genotype f1 origin, β-Galactosidase fragment, MCS, M13 forward priming site, 
T7 promotor/primer, KS primer, SK primer, T3 promotor, Lac 
promotor, pUC origin, AmpR  
Reference/Source Invitrogen
Table 2.3 pBluescript Cloning vector
 
  
       Figure 2.2 pBluescriptSK+ vector map
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Vector pGEX 6P.2
Size 4985bp
Genotype AmpR, pBR322 origin, Glutathion-S-Transferase gene, MCS, 
GEX3 and GEX5 primer
Reference/Source GE Healthcare
Table 2.4 Expression vector for GST tagged proteins
      
 
 
      Figure 2.3  pGEX6P-2 vector map
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Vector pET 25b+
Size 5547bp
Genotype T7 promotor, MCS, 6xHis tag coding sequence, T7 terminator, 
BR322 origin, f1 origin
Reference/Source Novogene/Merck
Table 2.5 Expression vector for 6xHis tagged proteins
               Figure 2.4 pET25b+ vector map
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2.3 Oligonucleotide Primer
All oligonucleotide primers used for cloning or RT-qPCR were synthesised at MWG Eurofins. 
M 13 Sequencing primer
forward 5ʼ GTAAAACGACGGCCAGT 3ʼ
reverse 5ʼ AACAGCTATGACCATG 3ʼ
T7 primer
Promotor 5ʼ TAATACGACTCACTATAGGG 3ʼ
Terminator 5ʼ GCTAGTTATTGCTCAGCGG 3ʼ
PNPLA3 qPCR Primers
Forward 5’ GTTGTCCAGGCATTGATCTG 3’
Reverse 5’ ATCACACTCCCCAGCAAAAG 3’
StAR qPCR Primer 
Forward 5’ CGTGGATCAGCCAGGTCCGCA 3’
Reverse 5’ TCACTCAGCATCCTCGGGGAC 3’
StAR full length cloning primers (GST tagged)
Forward 5’ AAGGATCCATGCTGCCCGCCACCTTCAAGC 3’
Reverse 5’ CGGGCAGCGGGCTGCTGAGAATTCAA 3’
AADA qPCR Primer
Forward 5’ GGCAGTGCTCTACTTCCAC 3’
Reverse 5’ TCCAGTGCAGTTTGAAGACG 3’
A LOC768489,  Gallus gallus  similar to LOC495387 protein
Forward 5’ GCTGTTAGCCAGACCCTGTC 3’
Reverse 5’ CACAAGCAAGACGTCCTGAA 3’ 
B arylacetamide deacetylase-like 4, gallus gallus LOC768457
Forward 5’ AGGTCCTGAAGGGCTCTCAT 3’
Reverse 5’ ATGAGACGGTGAAACGGTTC 3’
C LOC429936, Gallus gallus similar to LOC495387 protein
Forward 5’ CGAAGTCCATGAAGCAGTCA 3’
Reverse 5’ ACAACGGCATTCGAGTAACC 3’
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D LOC768597,  Gallus gallus similar to LOC495387 protein
Forward 5’ GCCCTCCTATCAGCAGAATG 3’
Reverse 5’ ACAACGGCATTCGAGTAACC 3’
E LOC768647,  Gallus gallus similar to LOC495387 protein
Forward 5’ AACCTGCCGCTATCTTGCTA 3’
Reverse 5’ TATTGTCTGTGGGGACAGCA 3’
F arylacetamide deacetylase-like 4, gallus gallus LOC495387
Forward 5’ CAAGGGGATACAACCCACAC 3’
Reverse 5’ AGGACAATGGAGTCCCAGTG 3’
G LOC768580, Gallus gallus similar to LOC495387 protein
Forward 5’ CGTGCTGCGTTCTATGTGTT 3’
Reverse 5’ ATGAGACGGTGAAACGGTTC 3’
H arylacetamide deacetylase-like 3, gallus gallus
Forward 5’ CTGTGTCAATGCCACCATTC 3’
Reverse 5’ CCAAAGATACGTGCCCAGAT 3’
I arylacetamide deacetylase-like 1, gallus gallus
Forward 5’ TGCTGTTTGTATGCCACCAT 3’
Reverse 5’ CTGCAAAGCAAGATGAACCA 3’
J arylacetamide deacetylase gallus gallus
Forward 5’ GGCAGTGCTCTACTTCCAC 3’
Reverse 5’ TCCAGTGCAGTTTGAAGACG 3’
β-Actin qPCR primers
Forward 5’ AGCTATGAACTCCCTGATGG 3’
Reverse 5’ ATCTCCTTCTGCATCCTGTC 3’
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2.4 Antisera and Antibodies
Antibody Dilution
Rabbit α chicken AADA 1:500
Mouse α chicken FABP4 1: 20000
Mouse α chicken PNPLA3 1: 1000
Mouse α GAPDH 1:15000
Mouse α 6x His 1:1500
Goat α rabbit IgG 1:50000
Goat α mouse IgG 1:1500
Goat α rabbit IgG Alexa 488 1:1000
Biotinylated goat α rabbit IgG 1:800
Streptavidin HRP 1:500
DAPI nuclei stain 1:4000
Table 2.6 Antisera and antibodies used for Western Blots and Immunostainings
2.5 Animals
White Leghorn laying hens (30-40 weeks old) were purchased from Heindl  Co. (Vienna, 
Austria) and maintained on layer’s mash with free access to water and feed under a daily 
light period of 16 hr.
2.6 Molecular Biological Methods: DNA
2.6.1 cDNA Synthesis
cDNA Synthesis was carried out using Superscript II Reverse Transcriptase (Invitrogen) after 
DNase I (Invitrogen) digest.  Superscript Reverse Transcriptase II produces first strand 
cDNA.
To get 1µg of cDNA, 1µg of RNA (obtained as described in 2.6.1) was used. To 1µg RNA, 1µl 
10x Buffer and 1µl  DNase I were added, adjusted with ddH2O to a final volume of 10µl  and 
then left on room temperature for 10min. 1µl  of 25mM EDTA was added and the reaction 
was inactivated by heating at 65°C for 15min.
Then 1µl  of 10mM dNTPs and 1µl  of Oligo dT Primer were added, the mixture was incubated 
on 65°C for 5min. It was then briefly chilled on ice before adding 4µl of First Strand Buffer 
and 2µl  of 1mM DTT. The mixture was incubated at 42°C for 1min. Thereafter 1µl  of Reverse 
Transcriptase (200U) was added and the solution was incubated at 42°C for 50min. The 
reaction was inactivated by heating at 70°C for 15min.
The cDNA was stored at -20°C until further use as template in PCR and RT-qPCR.
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2.6.2 Polymerase Chain Reaction (PCR)
All PCR reactions to amplify specific parts of DNA were performed using a T3000 
Thermocycler by Biometra. Polymerases used are listed in 2.1. The set up of the PCR 
reaction mix and of the PCR program is described in Table 2.7 and Table 2.8, respectively.
Table 2.7 PCR reaction mix                              Table 2.8 Example of a PCR program set-up
Specific primers for the desired fragment were used. The annealing temperature for each 
PCR program was adjusted for the melting points of those primers. The elongation 
temperature of each program was chosen depending on the length of the desired fragment.
 2.6.3 DNA Gel Electrophoresis
DNA gel electrophoresis was performed to separate different DNA fragments or PCR 
products by their size. DNA electrophoresis gels were prepared from 1% (w/v) StarPure 
Agarose (Starlab) and TAE buffer, containing ethidium bromide. Ethidium bromide 
intercalates with DNA and makes DNA visual under UV light. As a size marker, the 100bp 
ladder by Fermentas was used. Samples were mixed with  DNA loading buffer containing 
glycerol to increase the density of the sample, and insure that it stays within the gel  slots, 
and a stain (Bromphenol Blue or Xylen Cyanol) as a front marker.  The gel was run in TAE 
buffer at 100V for 30min. 
TAE Buffer               5x DNA loading buffer
2M Tris pH 8,0         50 % Glycerol
5,7% Acetic Acid     0.1 M EDTA 50x TAE Bromophenol blue or Xylen Cyanol FF
0,5M EDTA
                                                                      
2.6.4 DNA Gel Extraction
The gel extraction was performed using Quiagens QiaQuick Gel Extraction Kit. Bands were 
cut out of the agarose gel using a scalpel. 300µl of Buffer QC were added to the gel piece 
and the gel piece was molten at 50°C shaking. 100µl  isopropanol were added and the 
solution was mixed by inverting. It was then loaded onto a column and centrifuged for 30sec 
at full speed. 
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Initial Denaturation 94°C 5min
Denaturation
40 Cylces
94°C 30sec
Annealing xx°C 30sec
Elongation 72°C xxsec
Final Elongation 72°C 10min
Cooling 4°C forever
DEPC H2O 18,75µl
Buffer/MgCl2 2,5µl
DMSO 1,25µl
Primer fwd 0,5µl
Primer rev 0,5µl
dNTPs 0,5µl
cDNA 0,5µl
Polymerase 0,5µl                  
The flow through was discarded, 500µl Buffer QC were added to the column, and again 
centrifuged for 30sec at full speed. The flow through was again discarded, 700µl of Wash 
Buffer were added and the sample was centrifuged again. The flow through was again 
discarded and another brief centrifugation was done to remove all ethanol from the Wash 
Buffer. The column was then placed into a new collection tube and the sample was eluted 
from the column using 40µl of ddH2O.
Eluted DNA was stored at -20°C.
2.6.5 Vector Preparation
2.5.5.2 pBuescript SK+
1µg of pBluescript SK+ was mixed with 0,2µl  of Acetyl-BSA, 2µl  of EcoRV-Buffer and 1µl of 
EcoRV and then brought to a final volume of 20µl. The vector was digested for 1,5h at 37°C. 
The digest was then inactivated by heating at 65°C for 10min.
The now liniarised plasmid was then ready to use for ligation.
2.6.5.2 pGEX 6P.2
1µg of pGEX6P.2 vector DNA was mixed with 14µl  of dH2O, 2µl  Tango Buffer (Fermentas) 
and 1µl each of EcoRI and BamHI (both Fermentas) and then digested for 1,5h at 37°C.
The vector DNA was then loaded onto an agarose gel and the vector band was cut out and 
gel extraction was performed as described in 2.4.
2.6.5.3 pET 25b+
1µg of pET 25b+ vector DNA was added to 14µl  dH2O, 2µl  Tango Buffer (Fermentas) and 
1µl of NcoI and EcoRI (both Fermentas) each. The mixture was incubated for 1,5h at 37°C.
Then 13,5µl of 1M sodiumacetate, 27µl  of isopropanol  and 7µl dH2O were added. The 
vector DNA was precipitated either over night at -20°C or for 2h at -80°C.
After that, a DNA pellet was obtained by centrifugation for 30min at 13000rpm at 4°C.
The pellet was washed once with 70% ethanol and then dried for 5min at 37°C.
2.6.6 DNA Ligation
2.6.6.1 Ligation into pBluescript SK+
16µl  of gel extracted PCR product were added to 1µl  of EcoRV-digested and heat inactivated 
pBluescript SK+, 2µl  of ligation buffer and 1µl  of T4 ligase (both Promega) were added and 
ligation was performed over night at 18°C.
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2.6.6.2 Ligation into pGEX6P.2
After Midi-Preparation of the desired DNA sequence in pBluescript SK+, the DNA was 
digested using 5µg of Midi-DNA, 2µl  Tango buffer, 1µl EcoRI, 1µl  BamHI and water up to 
20µl, to produce sticky ends for ligation into pGEX6P.2. After digestion for 1,5h at 37°C, the 
DNA was loaded onto an agarose gel and the insert band was cut and gel extraction was 
done as described in 2.4.
Then 14µl of gel extracted insert DNA and 3µl  of gel  extracted pGEX6P.2 vector DNA were 
mixed with 2µl  ligation buffer and 1µl  T4 ligase and ligation was performed over night at 
18°C.
2.6.6.3 Ligation into pET 25b+
The desired DNA piece was obtained by digestion of 5µg of Midi-DNA with 2µl  Tango Buffer, 
1µl NcoI,1µl EcoRI and water up to 20µl. Digestion was done for 1,5h at 37°C and 
afterwards the DNA was loaded onto an agarose gel, after which the insert band was cut out 
and gel extraction was performed as described in 2.4.
17µl  of gel  extracted insert DNA were pipetted directly onto the dried pET 25b+ vector pellet, 
the pellet was resuspended and 2µl  of ligation buffer and 1µl of T4 ligase were added. 
Ligation was performed over night at 18°C.
2.6.7 Transformation of competent E.coli
A 50µl aliquot of One Shot TOP10 chemically competent E.coli (Invitrogen) was thawed. Per 
25µl  of cells, 5µl  of ligation reaction were added and the cells were incubated on ice for 
30min.
Cells were then heat-shocked at 42°C for 30sec to take up plasmid DNA. They were then 
briefly chilled on ice, 250µl of SOC medium were added and the cells were grown at 37°C for 
1,5 hour.
Cells were then spread onto LB plates containing either kanamycin (100mg/ml) for TOPO 
TA plasmids, ampicillin (100mg/ml) for pGEX6P.2 and pET25b+ or ampicillin and X-Gal for 
blue/white-selection of pBluescript SK+. Plates were put into a 37°C incubator over night.
2.6.8 Mini preparation of Plasmid DNA
For small scale preparation of DNA, the Promega Pure Yield Plasmid Mini Kit was used, for 
all  centrifugation steps an Eppendorf table top centrifuge was used. 600µl of bacterial  over 
night culture was mixed with 100µl  of Lysis Buffer and subsequently 200µl of Neutralization 
Buffer were added to stop the lysis reaction. The samples were centrifuged for 5min at 
13000rpm to pellet the precipitate.
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The cleared lysate was then put onto mini columns and the columns were centrifuged for 
1min at 13000rpm to allow binding of DNA. DNA was then washed first with 200µl of 
Endonuclease Removal Buffer and then with 400µl of Wash Buffer containing ethanol. DNA 
was then eluted into a fresh tube using 40µl  of pure water. The obtained DNA was stored at 
-20°C.
2.6.9 Midi preparation of Plasmid DNA
For medium scale DNA preparations, the Promega Pure Yield Plasmid Midi  Kit was used, all 
centrifugation steps were performed using the Sorvall GSA and HB-6 rotors. 100ml bacterial 
overnight culture were harvested by centrifugation for 15min at 3000rpm.  The pellet was 
then resuspended in 3ml Resuspension Buffer, 3ml of Lysis Buffer were added and cells 
were left to lyse for 3min. 5ml of Neutralization Solution were added and the solution was 
incubated on RT for 2min to allow a precipitate to form. The Lysate was then poured onto 
clearing columns and centrifuged for 5min at 2000rpm to separate the liquid containing the 
DNA and the precipitate. The cleared lysate was then transferred onto a DNA binding column 
and DNA was bound by centrifuging for 5min at 2000rpm. The DNA on the column was then 
washed first by adding 5ml of Endotoxin Removal Wash and centrifugation for 5min at 
2000rpm and then by adding 20ml of Wash Buffer and centrifugation for 10min at 2000rpm. 
The column was then placed into a new falcon tube and 500µl  of pure water were put onto 
the column resin to elute the DNA by centrifugation for 3min at 2000rpm.
DNA concentration was measured using a NanoDrop 2.0 Spectrophotometer.
2.6.10 Quantitative Real Time PCR (RT-qPCR)
Quantitative Real Time PCR serves to detect the level of transcription of a certain gene e.g. 
in various tissues or at different time points.  It is based on the classic PCR technique to 
amplify DNA, and simultaneously it allows the detection of the actual  amount of amplified 
transcript by fluorescence measurement. Fluorescing dyes that intercalate with dsDNA such 
as SYBR Green are added to the PCR reaction mix, and with each cycle of PCR the 
fluorescence signal becomes more intensive, as there is more dsDNA with which the dye 
intercalates. The DNA amount in the samples can be quantified using standard curves and 
the actual level of transcription can be calculated by normalizing the results of RT-qPCR to a 
house-keeping gene (β-Actin or GAPDH), also quantified with RT-qPCR. 
All  RT-qPCR experiments were done with a Roche LightCycler© 480. As SYBR Green 
mixes, either LightCycler® 480 SYBR Green I Master by Roche or  KAPA SYBR FAST qPCR 
LightCycler480 by PeqLab were used. Each PCR reation was set up as in Table 2.9
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Ultra pure water 4,5µl
Primer fwd. 25pmol 0,75µl
Primer rev. 25pmol 0,75µl
SYBR Mix 7,5µl
Table 2.9 qPCR Reaction Mix
To the 13,5µl  of Master Mix, 1,5µl of cDNA were added, either undiluted or diluted 1:10 in 
ultra pure water. The qPCR was then run using an appropriate program, adjusted to the 
melting temperatures of the primers used.
2.7 Molecular Biological Methods: RNA
2.7.1 Isolation of total RNA
Total RNA from tissues was isolated using TRIazol  Reagent (Applied Biosystems Inc.). 5ml 
TRI reagent was used per gram wet weight tissue (4-5g for fat tissues). The tissue sample 
was homogenized with the TRI reagent using an Ultra-Turrax homogenizer. Samples were 
incubated at RT  for 5min, then 200µl  of chloroform per ml of TRI were added, vortexed and 
incubated at RT for 15min.
The samples were then centrifuged at 12000g, 4°C for 15min. The clear upper phase 
containing the RNA was taken up and transferred into a new tube. 500µl  isopropanol  per 1ml 
of TRI were added, the samples were mixed by vortexing and then incubated at RT for 
15min.
Precipitated RNA was obtained as a pellet by centrifugation at 12000g, 4°C for 30min. The 
RNA pellet was washed once with 75% ethanol and then briefly air-dried. Depending on the 
tissue and on the size of the pellet, the pellet was resuspended in an appropriate volume of 
ultra pure water.
RNA concentrations were quantified using a NanoDrop 2.0 spectrophotometer.
2.8 Biochemical Methods: Protein
          
 2.8.1 Preparation of Triton X-100 Total Protein Extracts
1g of fresh or frozen tissue was homogenized in 4ml of homogenization buffer using an 
Ultra-Turrax T25 homogenizer. The samples were then centrifuged at 620x g at 4°C for 
10min. The supernatant was transferred into a new tube and 1/20 volume of  20% Triton 
X-100 was added. The solutions were briefly mixed and then left to incubate on ice for 
30min. The solution was then centrifuged in an Beckman ultra-centrifuge for 1h at 300.000 x 
g at 4°C. After centrifugation the supernatant was transferred in aliquots to new tubes and 
quick-frozen in liquid nitrogen. The protein extracts were stored at -80°C. Protein 
concentration was measured using the Bradford assay.
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Homogenization buffer
20mM HEPES, pH 7.4
300mM sucrose
150mM NaCl
0,5mM PMSF
2,5µM Leupeptin
2.8.2 Preparation of Triton X-100 Membrane Protein Extracts
5ml Buffer A were added to 1g of fresh or frozen tissue and the tissue was homogenized 
within the buffer using an Ultra-Turrax homogenizer until no more chunks were visible. The 
samples were centrifuged for 10min at 3000x g. The supernatant was then transferred into a 
new tube appropriate for ultra-centrifugation and was again centrifuged in an Beckman Ultra-
Centrifuge at 100.000x g for 1h at 4°C. The supernatant of this centrifugation was discarded 
and the pellet was resuspended using 3ml of Buffer A flushing it through a 18gge needle 
several times, followed by a few flushes with a 22gge needle. The samples were then 
centrifuged for 1h at 4°C at 100.000 x g.
The supernatant was again discarded and the pellet was resuspended in 1ml of Buffer B, 
flushing it through 18gge and 22gge needles as before. Then 4% of the total volume of 4M 
NaCl were added and the sample was sonicated for 30sec. 26% of the total volume of dH2O 
and 20% of the total volume of 5% v/v Triton X-100 were added and the samples were 
carefully mixed avoiding foaming. 
The samples were again centrifuged for 1h at 4°C, 100.000 x g. The supernatant 
representing the protein extract was stored in appropriate aliquots at -80°C after quick-
freezing in liquid nitrogen.
Protein concentration was determined using Bradford assay.
Buffer A                          Buffer B
20 mM Tris/HCl              250mM Tris/Maleat, pH 6
1mM CaCl2                     2mM CaCl2
150 mM NaCl                 Proteinaseinhibitor
Proteinaseinhibitor
 
2.8.3 Determination of Protein Concentration (Bradford)
For Bradford assays, Quick Start Bradford Dye and BSA (both from Biorad) were used. 1ml 
of Bradford reagent was mixed with 5µl of BSA, resulting in a final  concentration of 10µg/µl 
BSA. 1ml of reagent was mixed with 1µl  of protein extract or puried recombinant protein. 
Absorption of light was measured at 595nm wavelength, using 1ml  of Bradford as a blank, 
before measuring the samples.
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The protein concentration was calculated according to the formula below,.
c(BSA) µg       OD595nm
                   x                       = c(Protein) µg/µl
OD595nm        µl Protein 
                   
2.8.4 SDS-Polyacrylamide Gel Electrophoresis
In a molecular filter, such as an electrophoresis gel, molecules are supposed to be separated 
exclusively by their size. Under physiological conditions proteins are charged, and therefore 
won’t migrate through a gel simply according to their size. The charge of SDS masks the 
actual charge of the protein by binding to the protein. SDS is added to the rest of the gel 
components and also to the gel running buffer, so that the electrophoresis occurs under 
denaturing conditions.
Gels were prepared as in Table 2.10
Stacking Gel 
4%
10% 12% 14%
dH2O 1525µl 2025µl 1675µl 745µl
1,5M Tris HCl pH 8,8 - 1250µl 1250µl 1250µl
0,5M Tris HCl pH 6,8 625µl - - -
Bis-PAA 325µl 1650µl 2325µl 3255µl
10% SDS 25µl 50µl 50µl 50µl
10% APS 12.5μl 25µl 25µl 25µl
TEMED 5µl 5µl 5µl 5µl
Table 2.10 Preparation of Polyacrylamide Gels
Recombinant proteins and protein extracts were separated on 10%, 12% and 14% gels with 
a thickness of 0,75 mm using the BioRad Mini  gel system.  First, the components of the 
separation gels were mixed, the gel was poured, overlayed with isopropanol and 
polymerized for about 20min. The isopropanol was then rinsed off and the stacking gel 
components were mixed and poured onto the separation gel. A comb was placed into the 
liquid stacking gel to produce slots, and the gel was polymerized for 20min. Then the comb 
was removed, slots were rinsed with running buffer and the electrophoresis chamber was 
assembled and filled with running buffer.
Samples were prepared using 4x Laemmli  Buffer and 1M DTT to produce reducing 
conditions, samples were heated at 95°C for 10 minutes before being loaded onto the SDS-
PAA gel.
Gels were run at 100V for 10 minutes and then at 140V until the front marker ran out of the 
gel. After the gel run, either Coomassie Staining or Western Blotting was performed.
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Running Buffer        4x Laemmli buffer 
250mM Tris              8ml 78% glycerol
1,92M Glycine          6ml 20% SDS
1% SDS                   0.4ml 1M Tris-HCl pH 7.4 - 7.5
                                 ddH2O to a final volume of 20ml 
                                +25mM Dithiothreitol (DTT) for reducing conditions
 
2.8.5 Protein Detection by Coomassie Staining
After the gel run, SDS polyacrylamide gels were carefully detachted from the glas slide and 
then put into Coomassie Blue Staining Solution for one hour. The gel is stained by 
Coomassie and destained in Destain Solution, leaving only the proteins stained. The gel was 
vacuum dried at 70°C.
Coomassie Blue solution                                              Destain
10% Acetic acid                                                            10% Acetic Acid
25% Isopropanol                                                           30% MeOH in ddH2O
0.287g Coomassie Brilliant Blue R250 in ddH2O.
2.8.6 Western Blot Analysis
After the gel  run, proteins were transferred from the gel onto a Hybond-C membrane 
(Amersham) using the wet blot technique. A so-called “sandwich” was prepared: onto each 
side of a clamp two sponges soaked in transfer buffer were placed, three Whatman papers 
soaked with transfer buffer were placed onto each sponge. The gel was placed onto one part 
of the sandwich and an Hybond C nylon membrane was put onto it. Air bubbles were 
removed and the sandwich was clapped together. The sandwich in its clamp was placed into 
a transfer chamber (Biorad) filled with transfer buffer. Transfer was performed for 1h at 100V.
The membrane then was reversibly stained with Ponceau Solution to mark lanes and the 
marker proteins. The Ponceau was then removed with distilled water and the membrane was 
blocked with 5% dry milk in TBS-T for 1h at room temperature. Afterwards the membrane 
was incubated with the first antibody in an appropriate dilution over night at 4°C. Then, the 
membrane was washed three times with 1x TBS-T  and incubated for one hour at room 
temperature with the second antibody, anti  mouse IgG or anti rabbit IgG, respectively. After 
incubation with the second antibody, the membrane was washed as before, and then 
incubated with 1ml of Enhanced Chemiluminescence (ECL) Reagent. Then a film was 
exposed to the membrane in the dark room and developed using Developer and Rapid Fixer 
by AGFA.
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Ponceau S                     Transfer Buffer          TBS-T
0.2% Ponceau S             250mM Tris              250mM Tris
1x PBS                            1,92M Glycine         1,4M NaCl
3% Trichloracetic acid                                     25mM KCl
                                                                        1% Tween 20
                                                                
2.8.7 Expression and Purification of recombinant Proteins
Recombinant proteins were obtained from bacterial  expression cells, namely BL21 by 
Invitrogen whic  had previously obtained the DNA sequence coding for the protein. Cells were 
grown at 37°C  in LB amp medium until  an optical density OD600 of 0,6-0,7 was reached. 
Induction was achieved using Isopropyl  ß-D-1- thiogalactopyranoside (IPTG) at a final 
concentration of 1mM. 
Cells were grown for 3 hours and then harvested by centrifugation at 4°C for 10min at 3000 x 
g in a Sorvall  centrifuge using a GS-3 rotor. The cell  pellet was resuspended in 8M Urea 
containing protease inhibitors (Roche), and the samples were sonicated 12 times for 30 
seconds. The lysate was then centrifuged at 2300 x g for 10 minutes at 4°C. The cleared 
supernatant was transferred into a new tube and incubated over night in an appropriate 
binding buffer at 4°C, with either 500µl  Ni-NTA agarose (Quiagen) for His-tagged proteins or 
Glutathione sepharose B4 beads (Sigma) for GST-tagged proteins, respectively. 
On the next day, the beads were sedimented at 2300 x g for 5min at 4°C. The supernatant 
was transferred to a new tube as a control of protein binding to the beads. The beads were 
then washed three times in an appropriate washing buffer, and wash fractions were also 
stored as controls. The protein was finally eluted from the beads buffers containing either 
Imidazol for Ni-NTA agarose or L-Glutathione for Glutathione sepharose B4 beads, 
respectively. For elution the beads were incubated three times with 500-700µl of elution 
buffer for 30min at 4°C rotating. Protease inhibitor was added to the eluted protein samples.
The extent of purification was tested on SDS-PAA gels using Coomassie Staining.
Binding Buffer A      Binding Buffer B  
8M Urea pH8,5        TBS-T
Washing Buffer A    Washing Buffer B
8M Urea pH6,3        TBS-T
Elution Buffer A      Elution Buffer B
8M Urea                  TBS-T
100mM Imidazol     100mM Glutathion
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2.8.8 Antibody Generation
As insoluble proteins have to be eluted in 8M Urea, the urea concentration of the eluted 
peptide used for antibody generation is typically too high and could cause renal  failure in the 
animal used for antibody production. Thus, the solution has to be dialysed to remove the 
urea almost completely.
Dialysis buffers containing different concentrations of urea were prepared. Elutions were 
pooled in dialysis tubing and the sample was dialysed against each buffer for a minimum of 
three hours. The protein concentration was then measured using Bradford. The purified 
protein, a fragment of chicken PNPLA3 made up of 50 amino acids, located in the middle of 
ggPNPLA3, was then injected intra-dermally into either white Balb C mice or into a white 
New Zealand rabbit. Mice were given the peptide three times in intervals of three weeks with 
100µg of peptide at each injection. Rabbits were also injected three times with the peptide in 
intervals of three weeks, receiving 250µg of peptide with each injection. For all injections the 
purified protein was mixed with GEBRO complete adjuvant.
One week after the last injection, the antisera were obtained. The blood was incubated at 
RT for 1 hr and afterwards stored o.n. to let coagulation proceed, then the samples were 
centrifuged at 4000 rpm for 15 min. The supernatant representing the antiserum was 
aliquoted and stored at –20°C. The obtained serum was tested by Western blot analyses. 
Preimmune serum from the same rabbit served as control. 
Dialysis Buffer
25mM Tris HCl pH 7,4
100mM NaCl
5% Glycerol
Urea added up to 6M, 4M, 2M or 0M respectively
2.8.9 Chromogenic Esterase Assay using pNitrophenyl-Esters 
A commonly used assay used to determine lipase and/or esterase activity employs p-
nitrophenyl  (pNP) esters as substrates for a putative enzyme (Gilham and Lehner, 
2005).When these esters are cleaved by an enzyme, p-nitrophenol accumulates and makes 
a chromogenic  reaction, turning the buffer solution yellow. The change in colour can be 
quantified photometrically at a wavelength of 410nm. There are various types of esters 
available commercially, short-chain acyl esters such as p-nitrophenyl acetate, or longer chain 
acyl  esters e.g. p-nitrophenyl dodecanoate (also called p-nitrophenyl laurate). If an enzyme 
is capable of cleaving short-chain acyl esters, this is an indication for esterase acitivity; 
cleavage of long-chain acyl esters indicates lipase acitivity.
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For the assay, the putative esterase/lipase was freshly expressed and purified, at maximum 
2 days before the assay.  A basic buffer was prepared from Tris-HCl pH8, NaCl  and Triton 
X-100. Stock solutions of p-nitrophenyl acetate and p-nitrophenyl laurate in Ch2Cl2 were 
prepared. The freshly purified substrate was incubated with possible co-factors/activators for 
1h at room temperature before starting the assay. 20-50µl  of p-nitrophenyl ester stock 
solution was added to 10ml of basic  buffer under constant vortexing to mix the organic phase 
with the aqueous solution. Then 200µl of buffer containing substrate were added to each well 
of a 96-well plate and the enzyme prearations (different dilutions, co-incubated with co-
factors, etc.) were added to the substrate solution. The chromogenic  reaction was then 
observed by measuring the absorbtion of the solution at 410nm each 5min over 40min.
Basic Buffer                         Stock 1                                           Stock 2
20mM Tris-HCl pH8            200mM p-Nitrophenyl acetate        200mM p-Nitrophenyl laurate
150mM NaCl                       in CH2Cl2                                       in CH2Cl2
0,01% Triton X-100
Note: In assays of the activity against long-chain acyl esters, emulsifying agents, such as 
gum arabicum (0,01%) or Triton (up to 2%) should be added to the basic buffer. 
2.8.10 Fluorogenic Lipase assay using 4-methyl umbelliferyl heptanoate (MUH)
Another assay to test for lipase activity of a protein employs 4-methylumbelliferyl  heptanoate 
as substrate. The substrate is water-soluble and the methyl-umbelliferone compound is 
strongly fluorogenic after hydrolysis of the ester bond. Fluorescence is measured at 355nm 
(excitation) and 460nm (emission). However it is critical, that MUH resembles rather a 
monoacylglycerol than triacylglycerol (Gilham and Lehner 2003).
For the assay, freshly expressed and purified enzyme was used. Different dilutions of the 
enzyme were prepared in Buffer B, and co-incubations of the enzyme and putative co-factors 
were performed in Buffer B for 1h at room temperature – Buffer B was added to a total 
volume of 180µl.  10µl of a 100mM stock solution of MUH in Tetrahydrofuran were added to 
10ml of Buffer A just before the assay. The 180µl  Buffer B were mixed with 20µl of MUH in 
Buffer A in a 96 well  plate, resulting in a total  volume of 200µl. The samples‘ fluorescence 
was then measured each minute over 10 minutes using a VICTOR V2 fluorimeter.
Buffer A pH 8                                        Buffer B pH8                           MUH Stock
20mM Tris HCl                                     137mM NaCl                           100mM MUH         
1mM EDTA                                           2,7mM KCl                              in Tetrahydrofuran
300µM Sodiumtaurodeoxycholate         10mM Na2HPO4
in PBS                                                     2mM  KH2PO4
                                                                                              in PBS
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2.9 Immunohistochemistry
2.9.1 Isolation and Cultivation of chicken primary hepatocytes
Chicken primary hepatocytes were obtained from chicks either one day before or after 
hatching by decapitation and isolation of the liver. The liver was then rinsed with PBS and 
minced with a scalpel  into very small pieces. These pieces were incubated with Collagenase 
and DNase for 30min. The samples were centrifuged for 1min at 200 x g. The supernatant 
was aspirated and the cell pellet containing hepatocytes and erythrocytes was treated for 
5min with Ammonium-Chloride Buffer to swell and eradicate the erythrocytes.
The reaction was stopped by adding DMEM medium and the sample was again centrifuged. 
The isolated hepatocytes were then suspended in DMEM medium and cells were seeded at 
different concentrations onto coated 8well microscope slides. Cells were allowed to attach to 
the slide over-night at 37°C, 5% CO2. 
       Collagenase Buffer                        Ammonium-Chloride Buffer
        1,1ml Collagenase (150U/ml)        0,14M NH4Cl 
      0,15ml DNase                                 0,17M Tris.HCl pH 7,2
      2,25ml 400mM Glucose
up to 20ml with PBS
2.9.2 Fixation and Fluorescence Staining of chicken primary hepatocytes
Cells were removed from sterile conditions and the medium was sucked off, the cells were 
washed with PBS carefully so as to not detach them. A 4% paraformaldehyde solution was 
used to fix the cells, cells were incubated for 15min shaking at room temperature with PFA. 
Cells were again carefully washed twice with PBS and then permeabilized with 0,2% 
Tween-20 for 5min at room temperature. Cells were washed two more times with PBS and 
then incubated for 1h in Blocking Solution. Then, the cells were incubated over-night with 
different dilutions of the first antibody in blocking solution. Subsequently, cells were washed 
three times with PBS and incubated with the second antibody, (either goat-α-rabbit IgG-
Alexa 488 or goat-α-mouse IgG-Texas Red), and counter-stained with DAPI for 1h at room 
temperature. After incubation with the second antibody, cells were washed three more times 
with PBS and then mounted using Fluorescence Mounting Medium by Dako and covered 
with coverslips. The processed samples were analyzed under the fluorescence microscope 
(Zeiss).
PBS Buffer pH 7,3         PFA solution           Blocking solution
1,4M NaCl                      4% (w/v) PFA         1% BSA
25mM KCl                      1ml 5M NaOH         3% inactivated goat serum
81mM Na2HPO4            in PBS                    in PBS
15mM KH2PO4
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3. Results
In general, my diploma thesis had two aims: 
1)  To further examine chicken PNPLA3 expression at the mRNA and protein levels under 
     different conditions, such as in the fasted and refed state and after treatment with various
     reagents such as  hormones, LXR  agonists etc. As an antibody against chicken PNPLA3
     did not exist, a polyclonal antibody was raised by me. 
2) To investigate whether arylacetamide deacetylase (AADA) might take over the role of  
    HSL in the chicken.  Therefore, esterase and lipase assays were carried out, using AADA  
    and interaction partners of HSL.
3.1 Antibody Generation
To be able to observe the expression of PNPLA3 not only at the mRNA but also at the 
protein level, an antibody against chicken PNPLA3 (ggPNPLA3) was raised. Therefore, a 
150bp stretch of the chicken PNPLA3 cDNA, yielding a 50 amino acid polypeptide, was 
chosen for antibody production. The sequence of the ggPNPLA3 gene was obtained from 
the Ensemble Genome database (see. Fig. 3.1).
5’- GCTGAAGCATGTGCAGATGTTCTGGCATTGGCCAAAGAAGCTAGAAAGCGGAATCTTGGT 60     
    CCTCTTCATCCTTCATTTAATGTGATAAAGATAATAAGAGATGGGTTGATGAGAAATCTG 120    
    CCAGAAAACACTCACCTGTTGTCATCGGGCAGGCTGTGCATTTCACTGACTAGAGTCTCA 180    
    GATGGTAAAAACACACTGATATCTAATTTTAACTCTAAAGAAGAAGTTGTCCAGGCATTG 240    
    ATCTGTAGCTCATTTGTCCCAATTTATTGTGGCCTCATTCCGCCATCATTTAGAGGTGTG 300    
    CGCTACGTGGATGGAGGAATCAGTGACAACTTGCCTCAGTATGAATCTAAGAATACCATC 360    
    ACCGTTTCACCTTTTGCTGGGGAGTGTGATATCTGTCCAAAGGGGAATTCTGCCAACTTT 420    
    CATGAAATGAATGTGACCAACACCAGCATTCAGCTCAGTTTGGGGAACCTTTATCGTTTA 480    
    ACACAAGCACTCTTTCCTCCAGAACCTAAGGTACTAGGTGAGATCTGTGAGCAAGGATAT 540    
    TCAGATGCTTTTAAATTCCTGAAAGAGAATGGTATTCTGAATGACTCAATTTATGTCAGC 600    
    TTGTCCTTCACCAAAACAAATCCTCATGAAGCTGCACAACACATTGACTATATGAAGAAA 660    
    AGAAATAAGTCTGAAAACAGTAGAATGGAAACTTCACAAGTGGAAGTACTCGGTGAGCAG 720    
    ATGAAGCAAAATCCGTGGCCTCTGGAGAAGAGTATATTTGAGAGTCTACCTCCTAGGCTT 780    
    CGTAAAGCGCTTCAGGAAGCTTGTAAAGAACCAAATGGATTCTATGCTCAGTTCTCTAAA 840    
    CTCTTCCCAGTGCGGGTGATATCCTATCTGATGCTACCATATACACTACCTGTGGAGTCT 900    
    GCTTATTCTGCTGCTTTACGGTTAGTAAACTGGTTTCCTGACATGCCTGCTGATGTTCGA 960    
    TGGATGCAAGAACAACTTCTTCAGATTGCTGGTACAGTTTATTCCCAGGCAAAAAAGAGG 1020   
    CTGTTCTGTACATCCAGGAAAGACAATTACACAGCACTAAGGAAATGTCAGACTGCCCCG 1080   
    GCTACTGTGGAATTTCATTCTTCGTACTGCCATCTTAAAATGCCTCATTCTTCTGCGGAT 1140   
    ATTGAAACCTGGCTCTGGGAATCTTCGTGCTACATGGACTCTGTTATGAAACATACTTCT 1200   
    CCTAAGACAAAGGAGCAGTCAGACTTAAACTCCTATCCTAATTTTCTCCCAAATTCTGAT 1260   
    GAATCTGGTTTGGAAATAGATTTTGACTCCTCCTCAGAGACAAGTTTCCATAAACAGTGT 1320   
    CTTTCTGGAAATGAGTTT – 3’                                      1138   
Figure 3.1  The chicken PNPLA3 cDNA sequence. The 5’ ATG start codon as well as the 3’ Stop codon can not 
be shown, as the PNPLA3 gene sequence in the chicken is not completely known.  The region marked in light 
grey was chosen for antibody generation; letters in red signify primer binding sites  (green arrow = forward primer 
with  additional NcoI restriction site [AACCATGGTCACATCCAGGAAAGACAATTAC];  blue arrow = reverse primer 
with additional EcoRI restriction site [TTGAATTCGGGTCCATGTAGCACGAAGATTC]) 
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To introduce restriction sites that would facilitate the cloning into different vectors, 
nucleotides corresponding to certain restriction sites were added to the primers. A list of 
primers can be found in part 2.3.
In Figure 3.2 the protein sequence, deduced from the known PNPLA3 DNA sequence is 
shown. The peptide used for antibody generation is depicted bold red. A part of the PNPLA3 
sequence is still unknown, because of this the protein sequence does not start with the 
obligatory methionine residue.
AEACADVLALAKEARKRNLGPLHPSFNVIKIIRDGLMRNLPENTHLLSSGRLCISLTRVS 60     
DGKNTLISNFNSKEEVVQALICSSFVPIYCGLIPPSFRGVRYVDGGISDNLPQYESKNTI 120    
TVSPFAGECDICPKGNSANFHEMNVTNTSIQLSLGNLYRLTQALFPPEPKVLGEICEQGY 180    
SDAFKFLKENGILNDSIYVSLSFTKTNPHEAAQHIDYMKKRNKSENSRMETSQVEVLGEQ 240    
MKQNPWPLEKSIFESLPPRLRKALQEACKEPNGFYAQFSKLFPVRVISYLMLPYTLPVES 300    
AYSAALRLVNWFPDMPADVRWMQEQLLQIAGTVYSQAKKRLFCTSRKDNYTALRKCQTAP 360    
ATVEFHSSYCHLKMPHSSADIETWLWESSCYMDSVMKHTSPKTKEQSDLNSYPNFLPNSD 420    
ESGLEIDFDSSSETSFHKQCLSGNEF 446
Figure 3.2 PNPLA3 protein sequence. the C-terminally located peptide chosen for antibody generation is shown 
in bold red letters; in the recombinant protein a 6x His-tag is attached to the peptide.
The selected DNA fragment was amplified in a PCR reaction using LH liver cDNA (produced 
from tissue extracted total RNA) as a template. A polymerase with proof-reading function to 
prevent deletion or insertion of bases was used. The product of the PCR reaction was the 
desired 150bp PNPLA3 fragment with additional restriction sites (NcoI and EcoRI). The PCR 
product was visualized on a 1% agarose gel containing ethidiumbromide (see Fig. 3.3).
Figure 3.3 PCR for cloning of a PNPLA3 fragment used for antibody generation. M designates the 
marker (100bp DNA ladder by Biorad), the PNPLA3 fragment is well amplified and appears  as a thick 
band.
The PCR product was then cloned first in to a pBluescript and then into an pET25b+ vector. 
The pET25b+ vector is supposed to add a C-terminal 6xHis tag to the peptide. After the 
correctness of the fragments‘ sequence was confirmed, the fragment was transformed into 
E. coli BL21 expression cells and the protein expression was induced using 100mM IPTG 
(see Fig. 3.4).
___________________________________________________________________________RESULTS
  52
Figure 3.4 Induction of  the expression of  a  his-tagged PNPLA3 fragment in E.coli BL21. Bacterial 
cells were grown to OD600 0,6 and protein expression was induced using 100mM IPTG. After induction 
cells were allowed to grow for 2 hours. Cells  were harvested by centrifugation and resuspended in PBS. 
Samples were prepared for SDS-PAGE by adding reducing Laemmli Buffer. PAA-Gels  were Coomassie 
stained after electrophoresis. T0 = before induction; T2 = 2 hours after induction. The protein of 6kDa 
together with the 6kDa 6x His tag yielded a recombinant protein of 12kDa.
There was efficient expression of the desired tagged peptide but as the peptide was quite 
insoluble, purification was difficult. The protein was purified using a lysis buffer containing 8M 
urea. The protein was bound to Ni-NTA agarose beads and eluted from the beads employing 
a pH gradient from pH8 to pH4,5. Urea was eliminated using step-wise dialysis to decrease 
the urea concentration without precipitating the protein. 
After three injections of 100µg purified protein each every three weeks, the mice used for 
antibody generation were sacrificed and the antibody was tested for its function and specifity. 
A Western Blot was performed to test whether the antibody worked (see Fig. 3.5). The 
recombinant His-tagged PNPLA3 fragment was used as a control for the function of the 
antibody. 
Figure 3.5 Western Blot to test for function of the polyclonal mαggPNPLA3 antibody.  Purified 
recombinant protein also used for injection was used as control, 2µg of recombinant protein were loaded 
in  each lane  of a 14% PAA gel and  subjected to SDS-PAGE. Proteins were subsequently transferred onto 
a nitrocellulose membrane. The recombinant protein of 12kDA size was detected with the mαggPNPLA3 
antibody via the PNPLA3 fragment and also with the mα6xHis antibody via the His tag attached to the 
recombinant protein. No band is visible when the recombinant  protein is incubated with preimmune 
serum. The Western Blot was performed under reducing conditions.
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As expected, the protein is recognized by the mα6xHis antibody via the His-tag attached to 
the protein. Preimmune serum did not give an immunoreactive signal, whereas the immune 
serum contains antibody against chicken PNPLA3.  The antibody was shown to work in 
Western Blots both under non-reducing and, slightly better, under reducing conditions (data 
not shown). Therefore, all  further Western Blot experiments were performed under reducing 
conditions.
3.2 Monitoring of PNPLA3 expression in different tissues
In our model organism, the chicken, the expression patterns of all  patatin-like phospholipase 
family members in different tissues had been previously elucidated - at the mRNA level  - in 
our laboratory (Saarela et al. 2008). Thus, it was known that in the chicken the expression of 
PNPLA3 is highest in liver, muscle and testis (see Figure 3.6).
Figure 3.6 Expression of PNPLA3 mRNA in various chicken tissues (from Saarela et al., 2008)
In additional qPCR experiments, I also observed that expression was highest in liver, muscle 
and testis (see Figure 3.7). Furthermore, it was found that there are higher PNPLA3 
expression levels in the liver of the R/O chicken compared to wild type, and that PNPLA3 
expression is higher in hen liver than in rooster liver.
Figure 3.7 Expression of  PNPLA3 mRNA. cDNA was prepared  from 1µg/µl RNA and used diluted 1:10 in 
qPCR. Gene specific primers for the ggPNPLA3 and β-actin genes were designed; PNPLA3 expression was 
normalized to β-actin expression. Each chicken gene was analyzed three times using the Roche Lightcycler 480 
and two replicates of each tissue were employed in each analysis. Error bars indicate the standard deviation. 
Statistics were done using MS Excel.
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After raising an antibody against chicken PNPLA3, Western Blot was performed to monitor 
the expression of PNPLA3 in various tissues also at the protein level (see Figure 3.3).
  
Figure 3.8 Western Blot analysis  of  PNPLA3 expression in various tissues; 50µg of membrane protein 
extract of each tissue were loaded onto a 10% PAA gel  and subjected to electrophoresis. Proteins  were 
transferred to  a nitrocellulose membrane, PNPLA3 was detected  using a m-α-ggPNPLA3 polyclonal 
antibody diluted in 5% BSA-TBST.
Monitoring PNPLA3 at the protein level, some surprising results were found. Because in 
qPCR experiments mRNA expression was high in liver, muscle and testis, it was expected 
that in the Western Blot strong bands would appear in these tissues. In liver, and even 
stronger in the liver of R/O chicken, solid bands appeared as expected. But in e.g. muscle 
only a faint band appeared, and an even fainter one in testis, although mRNA levels in these 
tissues were especially high. Maybe this is due to poor stability of the mRNA or due to low 
translation rates.
3.3. Influence of fasting and refeeding on PNPLA3
It has been reported that PNPLA3 expression levels in humans and mice decrease upon 
fasting and increase upon refeeding (Liu et al. 2004, Moldes et al. 2006, Kershaw et al. 
2006).  Therefore an experiment to monitor the influence of fasting and refeeding on chicken 
PNPLA3 was designed. Two hens were fasted for 18 hours, one of them was then sacrificed, 
the other one was refed for 24 hours and sacrificed thereafter. Additionally, one hen was put 
on a high-energy fat diet for three weeks and sacrificed afterwards. Liver tissue was taken 
from these animals, mRNA was isolated from the tissues and transcribed to cDNA, and also 
liver membrane protein extracts were prepared. The cDNA was used in quantitative PCR, 
the protein extracts were used for Western Blot experiments.
As published for humans and rodents, also in the chicken, PNPLA3 levels decrease upon 
fasting and increase upon refeeding (see Fig. 3.9). Interestingly, after a period of fasting and 
subsequent refeeding the PNPLA3 expression rises dramatically, meanwhile it only 
increases slightly in chickens after a three week fat diet. 
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Figure 3.9 qPCR analysis of  PNPLA3 expression upon different nutritional  conditions. Gene 
specific primers  for the ggPNPLA3 and β-actin genes  were designed; PNPLA3 expression was 
normalized to  β-actin expression. cDNA was prepared from 1µg/µl RNA and used diluted 1:10 in qPCR. 
Each chicken gene was analyzed three times using the Roche Lightcycler 480 and two replicates of each 
tissue were employed in each analysis. Error bars indicate the standard deviation. Statistics were done 
using MS Excel.
Next, it was tested whether the expression observed at the mRNA level was similar to that at 
the protein level. Therefore, a Western Blot with the protein extracts obtained from liver 
tissue of fasted, refed and hens on high fat diet was performed. For detection of the PNPLA3 
protein the polyclonal mαggPNPLA3 antibody, was used and to detect GAPDH a mαGAPDH 
antibody was used as control.
As at the mRNA level, also at the protein level, PNPLA3 decreases upon fasting and 
increases upon refeeding (see Fig. 3.10): compared to the “normal/basal” LH liver sample, 
the band visible in the 18h fasted sample is weaker, whereas the band after refeeding 
appears much stronger. The signal in the three week fat diet liver sample is only slightly 
stronger than that in the basal  sample, but weaker than the band in the refed sample, 
showing the same pattern as at the mRNA level. The housekeeping gene GAPDH was used 
as control, the strength of the GAPDH signal  should appear quite similar in all  tissues to 
ensure that differences in the intensity of PNPLA3 bands are not due to uneven loading but 
to differential expression.
Figure 3.10 PNPLA3 protein levels upon different nutritional conditions. 50µg membrane protein 
extract per lane were subjected to  SDS PAGE and blotted onto a nitrocellulose membrane, the membrane 
was cut between the 50 and 37kDa markers, PNPLA3 was  detected on the upper part using m-α-
ggPNPLA3 antibody, GAPDH was detected on the lower part  using a mouse-α-GAPDH antibody. 
Antibodies were diluted in 5% BSA-TBST.
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The same experiment was performed with samples obtained from restricted ovulator (R/O) 
chicken: two R/O hens were fasted for 18 hours, one was sacrificed after that, the other one 
was refed for 24 hours before sacrificing it. Livers were isolated and protein extracts as well 
as RNA were prepared from them. RNA was then used to generate cDNA. qPCR and 
Western Blot were performed, using cDNA and protein extracts, respectively.
Basal  PNPLA3 expression levels in R/O hen liver are higher than in the wild type laying hen. 
In accordance to the wild type expression pattern, PNPLA3 expression in the liver of fasted 
R/O chicken decreases - but upon refeeding there is no sudden increase in PNPLA3 
expression as was observed in the wild type chickens (see Fig. 3.11). A possible explanation 
for this might be that the R/O chicken generally has more energy stores than the wild type 
chicken and therefore induction of PNPLA3 expression is attenuated following refeeding.
Figure 3.11 qPCR of  PNPLA3 mRNA expression in fasted/refed R/O chicken. Gene specific primers  for the 
ggPNPLA3 and β-actin genes were designed; PNPLA3 expression was normalized to β-actin expression. cDNA 
was prepared from 1µg/µl RNA and used diluted  1:10 in qPCR. Each chicken gene was analyzed three times 
using the Roche Lightcycler 480 and two replicates of each tissue were employed in each analysis. Error bars 
indicate the standard deviation. Statistics were done using MS Excel.
A Western Blot was performed with samples from liver tissue of fasted and refed R/O 
chickens. This blot is shown in Figure 3.12.  As before, GAPDH was used as a control for 
even loading. Here the band in the fasted R/O liver sample is clearly weaker than the other 
bands. Untreated R/O liver and the fasted/refed liver sample appear unchanged. Generally 
the bands are more intense than in the corresponding blot with wild type chicken tissues 
(Fig. 3.10) in agreement with PNPLA3 expression in the R/O chicken being higher.
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Figure 3.12 Expression of  PNPLA3 protein upon fasting and refeeding in R/O chicken. 40µg of 
membrane protein extract from liver tissue were loaded per lane onto a 10% PAA gel, proteins were 
blotted onto a nitrocellulose membrane and the membrane was cut in two pieces to  be able to detect  both 
GAPDH and PNPLA3. PNPLA3 was detected on the upper part using m-α-ggPNPLA3 antibody, 
GAPDH was detected on the lower part using a mouse-α-GAPDH antibody. Antibodies  were diluted in 
5% BSA-TBST.
Taken together, qPCR and Western Blot results suggest that PNPLA3 may play a role in the 
generation and storage of energy-rich molecules such as dietary lipids: in the R/O chicken, 
where lipid metabolism is quite abnormal, PNPLA3 expression is generally higher than in 
wild type chicken. Moreover, PNPLA3 expression decreases at both the protein and the 
mRNA level when animals are fasted; the exactly opposite expression pattern would be 
expected for a lipase. 
3.4 Influence of hormonal treatment on PNPLA3
Many genes in lipid metabolism have different expression patterns in the females compared 
to males. It was observed that this is also true for PNPLA3 which showed in qPCR 
significantly higher expression of mRNA in the hens‘ liver than in the roosters‘ liver. 
Therefore, the influence of oestrogen treatment on the expression of PNPLA3 in rooster liver 
was tested.
Roosters received treatment with oestrogen (one dose every 24h) over 48 or 72 hours, and 
were then sacrificed. The liver tissue was isolated and RNA and protein isolation was 
performed. RNA was transcribed to cDNA and cDNA and protein extracts were used in 
qPCR and Western Blot, respectively.
In qPCR experiments, in the liver of control roosters, PNPLA3 expression at the mRNA level 
was lower than in the liver of laying hens. When roosters were treated with oestrogen for 48 
hours, the levels of PNPLA3 expression in the liver increased and even exceeded the 
expression level  in laying hen livers. In livers of roosters treated for 72 hours with oestrogen, 
the level of PNPLA3 expression was even higher than after 48 hours of oestrogen treatment 
(see Fig. 3.13).  
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Figure 3.13 qPCR analysis for PNPLA3 mRNA expression in rooster liver after a hormonal 
treatment with oestrogen. Gene specific primers for the ggPNPLA3 and β-actin genes were designed; 
PNPLA3 expression was normalized to β-actin expression. cDNA was prepared from 1µg/µl RNA and 
used diluted 1:10 in qPCR. Each chicken gene was analyzed three times using the Roche Lightcycler 480 
and two replicates of each tissue were employed in each analysis. Error bars indicate the standard 
deviation. Statistics were done using MS Excel.
Again, the protein expression does not exactly mirror the mRNA expression pattern. As 
expected, in rooster liver there is less PNPLA3 protein than in laying hen liver. After 48 hours 
of oestrogen treatment, the rooster liver band appears as strong as that in the laying hen. 
But, although mRNA levels of PNPLA3 were high after 72 hours of oestrogen treatment, in 
the liver protein sample after 72 hours of oestrogen treatment, PNPLA3 protein expression 
appeared weaker than before (see Fig. 3.14).
Figure 3.14 PNPLA3 protein levels after estrogene treatment of  roosters (Western Blot under 
reducing conditions), 40µg of liver membrane protein extract per lane were subjected to SDS PAGE and 
blotted onto a nitrocellulose membrane, the membrane was cut between the 50 and 37kDa marker bands, 
PNPLA3 was detected on the upper part using m-α-ggPNPLA3 antibody, GAPDH was detected on the 
lower part using a mouse-α-GAPDH antibody. Antibodies were diluted in 5% BSA-TBST.
In conclusion, it was shown that treatment with oestrogen could abolish the sex-specific 
differences in PNPLA3 expression at both the mRNA and the protein level. 
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3.5 Influence of treatment with TO901317 on PNPLA3 mRNA expression
Recently it was shown in a mouse model that, as many other genes in lipid metabolism, also 
PNPLA3 expression seems to be regulated by LXR/SREBP signalling (Huang et al. 2010). 
Treatment of cells or animals with the LXR agonist TO901317 appears to increase the 
expression of PNPLA3 – at least in the liver. Therefore, it was tested whether TO901317 
would also affect PNPLA3 expression in the chicken and, if so, in which tissues. Chicken 
swere treated with either DMSO or TO901317 (which was dissolved in DMSO) for 72 hours 
and then sacrificed. RNA was isolated from various tissues and cDNA was prepared from 
RNA. Quantitative PCR was carried out using these cDNAs. Results were normalized to β-
Actin (Fig. 3.15).
Figure 3.15, PNPLA3 mRNA expression after treatment with TO901317 for 72h, blue bars indicate 
DMSO treated chicken (control), green bars  stand for chicken treated with the LXR agonist TO901317. 
Gene specific primers for the ggPNPLA3 and β-actin genes were designed; PNPLA3 expression was 
normalized to β-actin expression. cDNA was prepared from 1µg/µl RNA and diluted 1:10 before use in 
qPCR experiment. Each chicken gene was analyzed  three times using the Roche Lightcycler 480 and two 
replicates of each tissue were employed in each analysis. 
As expected, TO901317 treatment elevated clearly the level of PNPLA3 expression in liver 
and white adipose tissue (WAT). We can only speculate that in the chicken, the effect of 
TO901317 on PNPLA3 expression is not a direct one, but also depends on SREPB as 
shown previously in rodents (Huang et al. 2010). 
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3.5 Immunohistochemistry of PNPLA3 in primary hepatocytes
As the α-ggPNPLA3 antibody worked under reducing and also under non-reducing 
conditions, I attempted immuno-histochemical experiments to localize PNPLA3 in the cell.
Primary chick hepatocytes were isolated and cultured. They were then fixed to a microscope 
slide and stained with the m-α-PNPLA3 antibody, followed by incubation with a fluorophor-
conjugated α-mouse IgG antibody. Samples were allowed to dry over night. 
Samples were first monitored with a non-confocal fluorescence microscope to check if controls 
(samples incubated only with blocking solution or pre-immune serum) did not show fluores-
cence, and if immune samples incubated with the α-ggPNPLA3 antibody showed a fluorescing 
signal. This was true (data not shown due to poor image quality), thus the immune samples 
were also used in confocal  microscopy (Fig. 3.16).  Cell  nuclei  are stained with DAPI (blue), the 
PNPLA3 staining appears red. At least to some extent PNPLA3 appears to localize to lipid 
droplets (circular structures).
Figure 3.16 Confocal Fluorescence images  of  PNPLA3 stainings in chicken primary hepatocytes. 
Hepatocytes seeded onto microscope slides were cultivated for 24h before fixation and staining. Fixation 
was performed using 4% PFA. Cells were either incubated with pre-immune mouse serum, immune 
serum containing α-ggPNPLA3 antibody or neither of them. Sera were diluted in 2%BSA-PBS. The 
fluorophor conjugated  antibody Texas Red was used as secondary antibody and nuclei  were counter 
stained with DAPI. Pictures were taken on a Zeiss fluorescence microscope using AxioVision software. 
Lipid droplets appear as unstained circular structures.
While these results are promising despite their preliminary nature, further experiments 
clearly are required.
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3.6 Effect of fasting and refeeding on AADA
Arylacetamide deacetylase (AADA), an enzyme whose reported primary function is the 
detoxification of arylamides, was shown to have esterase activity as well  (Probst et al. 1994). 
Many esterases also have lipase activity (in fact it is difficult to exactly distinguish esterase 
and lipase activity). Therefore, the working hypothesis was that AADA in the chicken may act 
as a lipase which would substitute for HSL.
If AADA were a lipase, one would expect that its expression would increase upon fasting so 
that energy stores would be mobilized, and decrease again after refeeding. This was tested 
by qPCR at the mRNA level and by Western Blot at the protein level. To obtain the tissue 
samples needed for the experiment, chicken were fasted and refed as described for the 
experiment in 3.3.
qPCR experiments revealed that, as expected for a lipase, the mRNA levels of AADA in fact 
increased upon fasting and decreased again after refeeding (see Fig. 3.17).
Figure 3.17 qPCR analysis of  AADA expression upon fasting and refeeding, Gene specific primers for 
the ggAADA and β-actin genes were designed; PNPLA3 expression was  normalized to β-actin 
expression. cDNA was prepared from 1µg/µl RNA and used undiluted in qPCR experiment. Each chicken 
gene was analyzed three times using the Roche Lightcycler 480 and two replicates  of each tissue were 
employed in each analysis. Error bars  indicate the standard deviation. Statistics  were done using MS 
Excel. 
To monitor AADA expression at the protein level, a Western Blot using protein extracts from 
fasted and refed chicken liver tissue was performed. Samples were normalized using 
GAPDH as loading control. A polyclonal rabbit-α-ggAADA antibody was used to detect 
AADA. The Western Blot is shown in Figure 3.18: as expected form qPCR analysis, AADA 
protein was elevated in the fasted liver sample when compared to untreated liver and liver 
from hens refed after fasting.
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Figure 3.18 Expression of  AADA protein on fasting and refeeding. 50µg of liver membrane protein 
extract per lane were subjected  to SDS PAGE and blotted onto a nitrocellulose membrane. Each sample 
was loaded twice so that  AADA and GAPDH could  be detected  independently. AADA was dedected 
using rabbit-α-ggAADA antibody and GAPDH was detected using m-α-GAPDH antibody. Both 
antibodies were diluted in 5% Milk-TBST.
Summarizing the results of qPCR and Western Blots, AADA could in fact serve as a lipase in 
the chicken. However, AADA is only in liver present to high extent, but as true substitute for 
HSL its presence in adipose tissue would be important. Therefore, further elucidation of the 
role of AADA in lipid metabolism is required.
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3.6 Analysis of tissue specific expression of AADA isoforms
If our hypothesis that AADA takes over the function of HSL in the chicken (or avian species in 
general) were true, AADA should be highly expressed in adipose tissue, as is HSL. AADA 
expression is highest in the liver - however, there are proteins that share high similarity with 
AADA. Therefore, primers specific  for these „isoforms“ were designed, and in qPCR analysis 
it was tested, whether there was an isoform highly expressed in adipose tissue. Sequences 
of different AADA-like proteins were obtained from the NCBI nucleotide database. The genes 
and their corresponding primer pairs were designated with letters from A to J (full names and 
primer sequences are listed in 2.3).
AADA isoforms - mRNA expression
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Figure 3.19 qPCR analysis  of tissue specific expression of  AADA isoforms. Gene specific primers for 
the AADA-like genes designated  with letters A to J and the β-actin genes were designed;  expression of 
AADA-like genes was normalized to β-actin expression. cDNA was prepared from 1µg/µl RNA and used 
undiluted in qPCR experiments. Each chicken gene was analyzed two times using the Roche Lightcycler 
480 and two replicates of each tissue were employed in each analysis.  Red bars  = liver tissue;  yellow 
bars = adipose tissue.
All AADA like genes (designated A-I) have much lower expression levels than AADA  (J) itself 
(see Fig. 3.19). However, genes B and C showed higher expression than the other AADA-
like genes. And surprisingly, these two genes also showed higher expression in the adipose 
than in the liver tissue. However, expression in the adipose tissue was still low compared to 
classic Gallus gallus AADA (J). Further investigation of these two genes appears promising 
and is required to further examine the role of AADA in lipid metabolism.
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3.8 Cloning, expression and purification of ggStAR
As mentioned in 1.4.1 the steroidogenic  acute regulatory protein (StAR) was shown to 
interact with HSL (Shen et al. 2003). I wanted to test if StAR would also interact with AADA 
the putative HSL analogue in the chicken. Therefore I first cloned chicken StAR as full  length 
protein. 
Primers for ggStAR 5‘ and 3‘ ends were designed (see 2.3, the G.g. StAR sequence was 
obtained from the Ensemble genome browser) and the sequence coding for StAR was 
amplified in a PCR reaction, yielding a DNA fragment with the expected length of 900bp (Fig. 
3.20). 
 Figure 3.20 PCR amplification of the ggStAR gene; the 100bp DNA ladder (Biorad) was used as marker (M).
The PCR product was cloned into the pGEX6.2 vector and, after correctness of the 
sequence was confirmed, transformed into E.coli BL21 expression cells. By induction with 
IPTG, the expression of StAR was achieved (Fig 3.21). The amount of StAR increases after 
induction (T0) over three hours (T1-3). StAR has a size of 37kDA, the pGEX vector adds a 
GST tag of 26kDa to the protein which therefore appears as a band of 63 kDa.
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Figure 3.21 Expression of  ggStAR protein. BL21 cells were grown to OD600 0,7  and protein 
expression was induced using 100mM IPTG. Cells were grown for three hours;  each hour a sample was 
taken. Samples were centrifuged to harvest  cells, cell pellets were resuspended in PBS and reducing 
Laemmli Buffer was added. Cell lysates were loaded onto a 10% PAA gel and subjected to SDS-PAGE. 
After electrophoresis, proteins on the gel were Coomassie stained.
The protein was then purified using glutathione Sepharose 4B beads by binding and 
subsequent elution using 100mM glutathion. Protein concentrations were determined using 
Bradford assay and appropriate aliquots were used in Esterase Assays (see. 3.9).
3.9 Search for evidence that AADA substitutes for HSL in the chicken
In our opinion, AADA might serve as HSL analogue in the chicken.  Thus, I performed 
several experiments to test whether AADA has the ability to cleave esterase substrates such 
as para-nitrophenyl  esters and 4-methylummbelliferylheptanoate (MUH). I also tested 
whether known interaction partners of HSL, which increase the activity of HSL, would also 
influence the activity of AADA. This would indicate an interaction between AADA and 
interaction partners of HSL. These experiments are described in the following section.
3.8.1 AADA activity against pNP-esters
I tested whether AADA cleaves a short chain acyl  ester (para-nitrophenyl acetate) and also a 
long chain acyl ester (para-nitrophenyl dodecanoate); pNP-acetate is soluble in water, 
whereas to dissolve pNP-dodecanoate in water an emulsifying agent, such as Triton X-100 
and/or gum arabic, was added.
In addition to test the activity of AADA against pNP esters, I also tried pre-incubating AADA 
for 1h at room temperature with StAR and FABP4, two proteins that were previously shown 
to interact with HSL.  I also tried pre-incubating AADA with PMSF, a known lipase inhibitor 
which should abolish the activity of the enzyme against the substrate.
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In Figure 3.22 the activities of AADA alone, StAR alone, or AADA pre-incubated with StAR 
against pNP-acetate is shown. StAR alone had no activity against pNP-acetate, while AADA 
alone exhibited significant activity against this substrate. AADA pre-incubated with StAR 
showed higher activity against the substrate than AADA alone.
However, these experiments are of preliminary nature, and further experiments with 
modulated conditions (e.g. concentration curves with different concentrations of both AADA 
and StAR) are required.
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Figure 3.22 Activity of  AADA and StAR against pNP-Acetate. {a) line graph; b) bar graph} 400µg 
AADA/ 5µg StAR protein/ both togehter, respectively, were mixed with a Tris buffer containing the 
substrate at a final  concentration of 200µM. The cleavage of the substrate was monitored over 30 minutes 
at 410nm using a Victor V2 Spectrometer (Perkin Elmer). In b), the 30min time point, which is  still in the 
linear range (see a)), is depicted. Neg. Control = light blue; StAR = red; AADA = yellow; AADA pre-
incubated with StAR = green.
The increase in activity of AADA pre-incubated with StAR indicates that there might be some 
sort of interaction between the two molecules; however, when AADA was pre-incubated with 
FABP4 no increase in activity was observed (see Fig 3.23). Therefore, it is not probable that 
these two molecules interact. Both StAR and FABP4 showed no intrinsic  activity against 
pNP-acetate (Fig. 3.22 and 3.23). 
Figure 3.23 Activity of  AADA and FABP4 against pNP-Acetate. 400µg AADA/ 5µg FABP4 protein/ 
400ng AADA with 5µg FABP4, respectively, were mixed with buffer containing the substrate at  a final 
concentration of 200µM. The cleavage of the substrate was monitored at 410nm using a Victor V2 
Spectrometer (Perkin Elmer) over 30 minutes (also see Material and Methods). Here the 30min time 
point, which is still in  the linear range, is depicted. Neg. Control = light blue;  AADA = red; FABP4 = 
yellow; AADA pre-incubated with FABP4 = green.
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As shown above, activity against a short chain acyl ester indicates esterase rather than 
lipase activity. To determine whether AADA may also have lipase activity, a long chain acyl 
ester, pNP-dodecanoate, was tested as substrate. However, no activity against this substrate 
was detectable (compare Fig. 3.24 with Figs. 3.22 and 3.23). It remains to be determined 
whether there is indeed a lack of lipase activity or assay conditions need to be altered.
Figure 3.24 Activity of  AADA and StAR against pNP-dodecanoate. 400µg AADA/ 5µg StAR protein/ 
400ng AADA with 5µg StAR, respectively, were mixed with buffer containing the substrate at a final 
concentration of 200µM. The cleavage of the substrate was monitored at 410nm using a Victor V2 
Spectrometer (Perkin Elmer) over 30 minutes (also see Material and Methods). Here the 30min time 
point, which is still in the linear range, is depicted. Neg. Control = light blue;  AADA = red; AADA pre-
incubated with StAR = yellow.
Finally, it was tested whether the activity of AADA and/or AADA pre-incubated with StAR 
would be abolished by pre-incubation with PMSF, a known lipase inhibitor.
Figure 3.25 Effect of  PMSF on AADA activity. 400µg AADA/ 400ng AADA with PMSF/400ng AADA 
with  5µg StAR/ 400ng AADA with 5µg StAR and PMSF, respectively, were mixed with buffer containing 
the substrate pNP-Acetate at a final concentration of 200µM. The cleavage of the substrate was monitored 
at 410nm using a Victor V2 Spectrometer (Perkin Elmer) over 30 minutes (also see Material  and 
Methods). Here the 30min time point, which is still in the linear range, is depicted. Neg. Control = light 
blue; AADA = red; AADA pre-incubated with PMSF = yellow; AADA pre-incubated with StAR = green; 
AADA with StAR and PMSF = violet.
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PMSF in fact had the ability to inhibit AADA activity against pNP-acetate by about one fifth 
(Fig. 3.25, red and yellow bars). If AADA had been pre-incubated with StAR and PMSF the 
inhibition was almost complete (Fig. 3.26, green and violet bars). As I showed before, StAR 
alone did not exhibit activity against the substrate, but StAR pre-incubation stimulated AADA 
activity in this experiment by about 0,6-fold (60%).
3.8.2 AADA activity against MUH
It was tested whether AADA exhibits activity against MUH, either alone or when pre-
incubated with StAR and FABP4, respectively. As controls, also StAR and FABP4 alone were 
tested for activity against the substrate. 
AADA and StAR alone showed almost the same activity against the substrate (Fig. 3.26, red 
and yellow bars). When AADA and StAR were pre-incubated, the activity against MUH 
increased about 2-fold (Fig. 3.26, green bar). 
In the previously performed assay using pNP-acetate as substrate (Fig. 3.22, 3.23, and 3.25) 
StAR had not shown activity against the substrate, in contrast to its activity against MUH. I 
wanted to test whether PMSF inhibits the activity of StAR alone, as PMSF also inhibits 
AADA. PMSF indeed reduced StAR activity against MUH to levels of the negative control 
(Fig. 3.26, blue and purple bars).
Figure 3.26 Activity of  AADA and StAR against 4-MUH. 400µg AADA/ 5µg StAR/400ng AADA with 
5µg StAR/ 5µg StAR and PMSF, respectively, were mixed with buffer containing the substrate at a final 
concentration of 100µM. Fluorescence was  monitored at 355nm (excitation) and 460nm (emission) using 
a Victor V2 Spectrometer (Perkin Elmer) over 10 minutes (also see Material and Methods). Here the 
10min  time point, which is  still in the linear range, is  depicted. Neg. Control  = light blue; AADA = red; 
StAR= yellow; AADA pre-incubated with StAR = green; StAR and PMSF = violet.
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As for pNP-acetate, for MUH it was also tested whether pre-incubation with FABP4 affected 
AADA activity. FABP4 alone showed no activity against MUH (Fig. 3.27, red bar). AADA 
alone exhibited considerable activity against the substrate (yellow bar), but when AADA and 
FABP4 were co-incubated (green bar) activity levels - as in the assay using pNP acetate as 
substrate - did not reach or exceed the activity of AADA alone. Therefore, an interaction of 
AADA and FABP4 seems improbable. 
Figure 3.27 Activity of  AADA and FABP4 against MUH. 400µg AADA/ 5µg FABP4/400ng AADA 
with  5µg FABP4, respectively, were mixed with buffer containing the substrate at  a final concentration of 
100µM. Fluorescence was  monitored at 355nm (excitation) and 460nm (emission) using a Victor V2 
Spectrometer (Perkin Elmer) over 10 minutes (also see Material and Methods). Here the 10min time 
point, which  is still  in a linear range, is  depicted. Neg. Control = light blue; FABP4= red; AADA= yellow; 
AADA pre-incubated with FABP4 = green.
Taken the data of both esterase and lipase assays together, it can be concluded that chicken 
AADA has esterase activity (which has been shown for rodent AADA by Probst et al. 1994). 
Whether AADA also has lipase activity remains to be further elucidated, possibly by an assay 
that uses trigylcerid as substrate since AADA has activity against MUH but not against pNP-
dodecanoate. Whether StAR itself also has some sort of lipase activity should also be further 
examined, as StAR showed intrinsic activity against MUH (but not against other substrates) 
and could be inhibited by PMSF. 
The preliminary experiments performed here form the basis for further, more detailed, 
studies on the enzymology of chicken AADA.
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4. Discussion
4.1 Investigation of chicken PNPLA3
Patatin-like phospholipases have gained importance in the investigation of lipid metabolism 
when ATGL (PNPLA2) was shown to be the key lipase in the break-down of TG 
(Zimmermann et al. 2004) particularly because for long time HSL was thought to be the only 
enzyme important in this process. ATGL and PNPLA3 whose expression is induced by 
exactly opposite conditions, are now extensively investigated in mouse models and in clinical 
investigations in humans. Little is known, however, about patatin-like phospholipases in 
avian species such as the domestic chicken. 
This work was focussed in part on PNPLA3. To investigate this family member, a polyclonal 
antibody against the chicken enzyme was raised, to facilitate investigations on PNPLA3 
expression in the chicken at both the mRNA and the protein levels, employing qPCR and 
Western Blot, respectively. 
The first striking results were obtained when PNPLA3 protein expression was monitored with 
the newly obtained antibody in various tissues. qPCR data on PNPLA3 expression in 
chicken was available (Saarela et al. 2008), which showed that PNPLA3 expression at the 
mRNA level  was high in liver, muscle, and testis, but low in, e.g., small intestine, colon, and 
the yolk sac  (Fig. 3.8). However, at the protein level, a different picture was observed: as 
expected from the qPCR data, expression was highest in the liver. But in muscle and testis, 
no PNPLA3 protein could be detected; however, in Western Blot experiments strong bands 
in small  intestine and yolk sac tissue appeared (Fig. 3.10). These data suggest that PNPLA3 
may serve as a protein promoting lipid storage: in the small intestine, a major site of lipid 
digestion, PNPLA3 may act, while dietary fat is digested, to recruit lipids to peripheral sites of 
lipid storage. Also, the high protein level of PNPLA3 in the yolk sac suggests a role in lipid 
storage: energy-rich yolk precursors have to be transported to and stored in the yolk, so that 
the embryo‘s energy supply is ensured - PNPLA3 could also affect these transport and 
storage processes. Finally, the fact that in RO liver and RO adipose tissue more PNPLA3 
protein is present (Fig. 3.10) suggests that PNPLA3 is involved in promoting lipid storage.
As published before for humans and rodents (Johansson et al 2006; Moldes et al. 2006), we 
found that in the chicken, PNPLA3 expression also decreases upon fasting and increases 
again after refeeding at both the mRNA and the protein level. In livers of laying hens that 
were fasted for 18 hours and then refed for 24 hours, a sudden increase in PNPLA3 
expression was observed. In these hens the level of mRNA expression even exceeded basal 
PNPLA3 expression (see. Fig. 3.9). In contrast, in fasted and refed RO hens, the decrease in 
PNPLA3 expression upon fasting is is not followed by an increase upon refeeding (Fig. 3.11). 
The pattern for mRNA levels was also observed at the protein level ( Fig. 3.10 and 3.12). 
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These data support a role for PNPLA3 in energy storage: in laying hens energy stores 
exhausted after fasting may have to be efficiently re-filled in the refeeding period, whereas 
RO hens having more energy stores, may not need to re-fill their reservoirs quickly and 
therefore may not up-regulate PNPLA3 expression to such a high extent as laying hens.
Interestingly, in hens that had received a fat diet for 3 weeks, PNPLA3 expression did not 
increase much, and expression of PNPLA3 mRNA is significantly lower in chickens on the fat 
diet than in fasted and re-fed chickens (Fig. 3.9 and 3.10). This expression pattern may be 
related to the so-called yo-yo effect observed in humans after restrictive diets: upon return to 
a former/normal life style after a period of low energy diet, often the body weight increases 
rapidly and may even surpass the weight before the diet. This may occur because the 
system interprets a low energy diet as famine, and when this diet stops, regulation is such as 
to restore all  energy depots in anticipation of another period of scarcity. In comparison, if 
there is a constant small  energy intake surplus, the body will also store some of the energy, 
leading to elevated body weight. 
Many genes in lipid metabolism are differentially expressed in the female and male, possibly 
related to females having relatively more adipose tissue than males. Rooster liver expresses 
less PNPLA3 than laying hen liver. By treatment of roosters with oestrogen, I showed that 
this difference in PNPLA3 expression was abolished. Both at the mRNA and protein levels 
there was a significant increase in PNPLA3 expression when roosters were treated with 
estrogen for 48 or 72 hours, respectively (see Figs. 3.13 and 3.14).
A recently published paper showed that PNPLA3 in rodents is, as many other genes involved 
in lipid metabolism, regulated by Liver X Receptor (LXR) and SREBP signaling (Huang et al. 
2010). To determine whether this was also true in the chicken, hens were treated with 
TO901317, an LXR agonist. In liver and white adipose tissue (WAT), a significant increase of 
PNPLA3 expression was observed in treated hens (Fig. 3.15). Thus, in the chicken PNPLA3 
expression is also regulated via LXR/SREBP signaling. In rodents, SREBP was abolished to 
show that the regulation of PNPLA3 is not only dependent on LXR but also SREBP 
signaling; as knock-out methodology is not available for chickens, dependence of the LXR 
effects on SREBP cannot be demonstrated yet.
The immunohistochemical experiments in primary hepatocytes to localize PNPLA3 within the 
cell  were of preliminary nature (see 3.16), but promising. Future studies are aimed at 
determining where in the cell PNPLA3 resides.
 
In conclusion, while a role in lipid storage for PNPLA3 has already been proposed, there are 
contradicting data on its putative function; e.g., although it is known that PNPLA3 possesses 
a G-X-S-X-G lipase motif and lipase activity in vitro, lipase activity could never be detected in 
vivo(Lake et al. 2005). My data on galline PNPLA3 support the hypothesis that this protein 
has a role in promoting nutrient storage rather than in lipolysis. 
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4.2 Investigations about chicken AADA
Although ATGL is present in the chicken and likely serves in breaking down TG, an analogue 
for HSL in the chicken has never been identified. It is unclear how DG are broken down in 
this organism.  AADA was shown to act not only as a carcinogen-detoxifying enzyme, but 
also as a carboxylesterase (Probst et al. 1991), able to cleave substrates such as para-
nitrophenyl  acetate or 4-methyl  umbelliferylheptanoate (MUH). Our working hypothesis 
therefore was that in the chicken AADA (which shows particular homology with mammalian 
HSL) takes over the role of HSL. We tested this hypothesis in several ways.
First, as AADA is primarily expressed in the liver, while HSL is mainly expressed in the 
adipose tissue, we searched for AADA-like proteins in the NCBI nucleotide database and 
obtained ten hits. Of these ten proteins „AADA-like protein 4“ and „Gallus gallus LOC429936 
similar to LOC495387 protein“, had higher expression in adipose tissue than in liver. 
Nevertheless, the total  mRNA level of these two proteins was much lower than the mRNA 
level of chicken AADA in liver and adipose tissue (see Fig. 3.20). For an HSL analogue, high 
expression in adipose tissue would be a crucial characteristic - from the data of this 
experiment, it is difficult to conclude whether or not AADA could be an analogue of HSL in 
the chicken, but future studies will focus on this point.
Second, it was monitored how AADA expression changes upon fasting and refeeding at both 
the mRNA and protein levels. One would expect that a lipase‘s expression increases upon 
fasting, as energy stores need to be mobilized, and decreases when food is supplied again. 
AADA showed, both at the mRNA level (quantitated with qPCR) and at the protein level 
(Western Blot), this expression pattern (Fig. 3.18 and 3.19). This supports the possibility that 
AADA could indeed act as a lipase and may substitute for HSL in the chicken. The above 
mentioned two AADA-like genes may be even stronger candidates for this role, and will be 
studied further.
In enzymatic assays using pNP-acetate, pNP-dodecanoate, and MUH as substrates it was 
tested whether AADA had activity against these substrates and whether the activity of AADA 
would change upon co-incubation with known HSL interaction partners (StAR and FABP4) or 
PMSF, a known esterase inhibitor. 
AADA alone, and even more so if co-incubated with StAR, had significant activity against 
pNP-acetate (Fig. 3.22), while co-incubation with FABP4 did not result in any increase of 
AADA activity against pNP-acetate (Fig. 3.23). Co-incubation of AADA and AADA/StAR with 
PMSF resulted in inhibition of enzymatic activity against the substrate (Fig. 3.25). Both StAR 
and FABP4 showed no activity against the substrate.
No AADA activity was detectable against pNP-dodecanoate, with or without co-incubation 
with StAR. According to (Gilham and Lehner 2005), activity against short chain acyl  esters 
like pNP-acetate indicates esterase activity rather than lipase activity and vice versa. Thus, it 
can be assumed that AADA has esterase rather than lipase activity.
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In a second enzymatic  assay that tests lipase activity using MUH (a fluorogenic  compound) 
as a substrate, AADA showed activity, indicating that AADA exhibits lipase activity. This 
observation is compromised by the fact that StAR alone shows PMSF-inhibitable activity 
against this substrate (Fig. 3.26). No lipase motif is present in the StAR protein, and also 
blasting StARs‘ protein sequence does not give any other hits apart from START family 
members, thus, it remains unclear why StAR alone is able to cleave MUH.
Because StAR and AADA had activity against MUH it is difficult to say if the increase in 
activity against MUH observed when AADA and StAR are co-incubated is due to interaction 
of the two proteins or is merely an additive effect (Fig. 3.27). As for pNP-acetate as 
substrate, FABP4 did not influence or modulate AADA activity against MUH (Fig. 3.27).
Considering these results, the role of galline AADA remains unclear. However, as expected 
for an enzyme with lipase activity, AADA expression changes upon fasting and refeeding: the 
expression rises upon fasting when energy stores need to be mobilized and drops again 
when food is supplied. AADA-like proteins expressed in the adipose tissue could be found, 
but the regulation of these genes has not been analyzed yet.
AADA showed activity against pNP-acetate, a substrate whose cleavage more likely 
indicates esterase activity, and against MUH which indicates lipase activity, but not against 
pNP-dodecanoate, another substrate whose cleavage would suggest lipase activity. The lack 
of AADA activity against pNP-dodecanoate could, however, also be a result of yet insufficient 
experimental conditions. An interaction between AADA and FABP4, an interaction partner of 
HSL (Shen et al. 1999) was not detected. In enzymatic  assays incubation of AADA with 
FABP4 had no effect on AADA activity, and also in ELISA experiments an interaction of these 
proteins could not be demonstrated (data not shown).
It is not yet possible to speculate on an interaction of AADA with StAR, a protein previously 
shown to interact with HSL (Shen et al. 2003). StAR had no endogenous activity against 
pNP-acetate, but co-incubation of AADA and StAR resulted in a significant increase of the 
activity of AADA. StAR alone already exhibited activity against MUH and so did AADA, 
therefore the increase in AADA activity against the substrate remains difficult to interpert. 
Moreover, in ELISA experiments an interaction between StAR and AADA could not be 
detected, and the same is true for Ligand Blotting experiments with these two proteins (data 
not shown). 
To further elucidate whether or not AADA exhibits lipase activity will  require the examination 
of its activity against true triglyceride molecules. To further investigate the interaction of 
AADA and StAR, StAR’s activity against such substrates must be tested.
Also, it would definitely be interesting to further examine StAR‘s lipase activity despite the 
absence of common lipase features in StAR: the half-life of StAR is much longer than 
required for acute responses and it has been hypothesized that StAR might fulfill  additional 
functions in the cell (Miller, 2007). Chicken AADA may offer a chance to shed light on this 
possibility.
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6. Abbreviations
A           
  α   alpha, anti
  A   adenin
   AADA                            Arylacetamide Deacetylase
 Apo   apolipoprotein
 APS   ammonium persulfate
 Amp   ampicillin 
  ATGL                              adipocyte triglyceride lipase 
 
B           
  bp   base pair 
C           
 C   cytosine
 CE   cholesterolester
 cDNA   complementary DNA
  CGI-58                           comparative gene identification 58
 CaCl2   calcium chloride
 C-terminus  carboxy-terminus
D           
 DG                                diglyceride
   DNA              deoxyribonucleic acid
 DTT              dithiothreitol
E           
 EDTA   ethylenediaminetetraacetic acid
 ECL   enhanced chemiluminescence
 ER   endoplasmic reticulum
F                                                                                                  l
 FFA                                free fatty acid
  
G           
 G   guanine
 gg   gallus gallus
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H           
  HDL   high-density lipoprotein
   HRP   horseraddish peroxidase
   HSL                               hormone sensitive lipase
  hs   homo sapiens
  His   histidine
  h   hour
I           _____
 IPTG   isopropyl β-D thiogalactoside
 IgG   immunoglobulin G
K           
 KCl                                potassium chloride
   kDa   kilo Dalton
 kb   kilo bases
L           
 LD                                  lipid droplet
  LDL   low-density lipoprotein
 LB   luria broth
 LDLR   low-density lipoprotein
 LH   laying hen
 LXR   liver X receptor 
M           
 µ   micro
 mM   milli molar
 mA   milli ampere
  mRNA   messenger ribonucleic acid
  MG                                 monoglyceride
  Mm   mus musculus
  
N           
 nm   nano meter
 NTP   nucleoside triphosphate
 N-terminus  amino terminus
 Ni-NTA   nickel nitriloacetic acid  
O           
 o.n.   overnight
 OD   optical density
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P           
 PNPLA                           patatin-like phospholipase domain containing
  PCR   polymerase chain reaction
 PBS   phosphate-buffered saline
 PAA   polyacrylamide
 PAGE   polyacrylamide gel electrophoresis
R           
 RT   room temperature
 rpm   rounds per minute
 RNA   ribonucleic acid
 R/O   restricted ovulator
 RT-PCR  reverse transcriptase polymerase chain reaction
S           
 SDS   sodium dodecyl sulfate 
 SNP   small nucleotide polymorphism
   SREBP                           sterol response element binding protein
   StAR                               steroidogenic actue regulatory protein
T           
 TG   triglyceride
 T   thymine
 TEMED   N,N,N',N'-Tetramethylethylenediamine
 TBS   tris-buffered saline
   TMB                               tetramethylbenzidine
U           
 UV   ultra violette
V           
 V                                    Volt
  VLDL   very-low density lipoprotein
 VTG   vitellogenin
Y           
 YS   yolk sac
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